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ABSTRACT 
Cedillo, Jessica. The Effects of Fish Meal Supplementation on Gene Expression 
in the Bovine Corpus Luteum Following Low Dose Administration of 
Prostaglandin F2α. Unpublished Master of Science thesis, University of 
Northern Colorado, 2018 
 
The corpus luteum is a transient endocrine gland that develops from the 
remnants of the ovulatory follicle and secretes the steroid hormone progesterone.  
Progesterone is essential in the establishment and maintenance of pregnancy in 
all mammalian species.  In the non-pregnant bovine, uterine prostaglandin F2α is 
secreted in a series of pulses between days 15 and 17 after ovulation, allowing 
the corpus luteum to undergo functional and structural regression and an 
opportunity for mating.  During early pregnancy, trophoblastic cells of the 
developing embryonic placenta secrete interferon-tau, which attenuates uterine 
prostaglandin F2α secretion allowing for maintenance of the corpus luteum 
during the period referred to as maternal recognition of pregnancy.  Inadequate 
secretion of interferon-tau or a delayed signal from trophoblastic cells can lead to 
luteal regression and loss of the pregnancy.  Thus, altering luteal responsiveness 
to prostaglandin F2α during maternal recognition of pregnancy may prevent early 
embryo loss.   
Inclusion of omega-3 fatty acids into the diet may be a novel approach to 
regulate luteal function during early pregnancy.  Supplementation with omega-3 
fatty acids in the diet has been shown to incorporate into luteal tissue, resulting in 
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altered membrane ultrastructure and mobility of the prostaglandin FP receptor.  
However, the effects of omega-3 fatty acids on luteal sensitivity to prostaglandin 
F2α is lacking. It was hypothesized that omega-3 fatty acid supplementation from 
fish meal may have a luteoprotective effect on the expression of immediate early 
genes (NR4A1 and FOS), key luteotropic (STARD1, CYP11A1, 3βHSD, and 
LDLR), luteolytic (PGHS2 and PTGFR), and apoptotic genes (BAX, BCL-2, and 
CAS3) that regulate luteal ability to produce progesterone and the longevity of 
the gland.  Administration of prostaglandin F2α resulted in downregulation of 
luteotropic genes and PTGFR, upregulation of immediate early genes and no 
change in apoptotic genes and PGHS2 regardless of luteal function.  
Supplementation with fish meal resulted in a decrease in BAX expression as 
compared to corn gluten meal supplementation.  Outcomes from proposed 
studies bridge our current gap in knowledge regarding the influence of dietary 
supplementation of omega-3 fatty acids on luteal function and gene expression in 
response to prostaglandin F2α.  The dietary supplementation of omega-3 fatty 
acids may be a strategy to improve reproductive performance in breeding 
females.    
 
 
 
 
 
 
 v 
 
 
 
 
 
ACKNOWLEDGMENTS 
 I would primarily like to thank my advisor, Dr. Patrick Burns for all of his 
guidance and support throughout my tenure at UNC.  He supported me not only 
throughout graduate school but from the day I began my undergraduate career in 
2014.  I am eternally grateful. 
I would also like to thank my parents for supporting me from the distant 
reaches of California.  I could not have accomplished any of this without you 
both.  I am grateful for my entire family’s support throughout my journey here.  
Additionally, I would like to extend thanks to the University of Northern 
Colorado School of Biological Sciences faculty, staff, and graduate students.  I 
would like to thank my committee members, Dr. Nicholas Pullen, Dr. James 
Haughian, and Dr. Ann Hawkinson for all of your guidance.  I would also like to 
thank the staff at the Colorado State University ARBL facility for assistance with 
animal care.   
I would like to thank my boyfriend, Zachary, for the unending support 
before and throughout my Master’s degree.   
Finally, I would like to thank my funding source, the National Research 
Initiative grant number 2013-67015-20966 from the USDA National Institute of 
Food and Agriculture.  
 
 
 
 vi 
 
 
 
 
 
TABLE OF CONTENTS 
CHAPTER  
I. INTRODUCTION AND REVIEW OF LITERATURE…………..………     1  
History of the Corpus Luteum  
Introduction to Problem 
Bovine Estrous Cycle  
The Corpus Luteum  
Progesterone Biosynthesis  
Luteolysis  
Immediate Early Gene Expression  
Luteotropic Gene Expression  
Luteolytic Gene Expression  
Apoptotic Gene Expression  
Omega-3 Polyunsaturated Fatty Acids  
Specific Aims 
Aims, Research Questions, and Hypotheses 
Conclusion  
  
II. METHODOLOGY………………………………………………..……...     25  
Animal Husbandry and Luteal Biopsy Collection 
Total RNA Extraction and cDNA Synthesis  
Primer Design and Optimization  
Quantitative PCR Protocol  
Statistical Analysis  
  
III. RESULTS ………………………………………………………………     34  
Immediate Early Gene Expression  
Luteotropic Gene Expression  
Luteolytic Gene Expression  
Apoptotic Gene Expression  
  
IV. DISCUSSION…………………………………………...………..……     48  
  
V. CONCLUSION………………………………………………..……...…     55  
  
REFERENCES……………………………………………………..……...     57 
 
APPENDIX  
A. Institutional Animal Care and Use Committee Approval…..............     82    
B. Primer Optimization Curves …………………………………………..     85 
 vii 
 
 
 
 
 
LIST OF TABLES 
TABLE  
1. Dietary supplementation ingredients, chemical composition,  
and fatty acid profile…………………………………..……......….…      27  
  
2. Gene name, primer sequences, accession numbers, product length 
and efficiencies……………….………….…………………………....      31 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 viii 
 
 
 
 
 
LIST OF FIGURES 
FIGURE 
1. Diagram of phases of estrous cycle and fluctuations of  
progesterone, estradiol, luteinizing hormone, and follicle  
stimulating hormone concentrations…………………………….....…     6 
 
2. Representation of progesterone biosynthesis pathway in the  
bovine corpus luteum………………………………………………….     10 
 
3. Schematic diagram of experimental design and  
supplementation…………………………………………….……….…     26 
 
4. Effect of corn gluten meal or fish meal supplementation on 
immediate early steady-state mRNA expression following low  
dose administration of prostaglandin F2α……………………….…..     35 
 
5. Effects of corn gluten meal or fish meal supplementation on  
steady-state mRNA expression of LDLR following low dose 
administration of prostaglandin F2α……………………..…………..     39 
 
6. Effects of corn gluten meal or fish meal supplementation on 
steady-state mRNA of STARD1 expression following low  
dose administration of prostaglandin F2α…………….……………..     40 
 
7. Effects of corn gluten meal or fish meal supplementation on 
steady-state mRNA levels of CYP11A1 in response to low  
dose administration of prostaglandin F2α……………………….…..     41 
 
8. Effects of corn gluten meal or fish meal supplementation on  
steady-state mRNA levels of 3βHSD in response to low dose 
administration of prostaglandin F2α…………………………….……     42 
 
9. Effects of corn gluten meal or fish meal supplementation on  
steady-state mRNA levels of luteolytic genes  
(PTGFR and PGHS2) following low dose administration of 
prostaglandin F2α…………………………………………..……….…     44 
 
 
 ix 
 
10. Corn gluten meal or fish meal supplementation on apoptotic 
genes (BAX, BCL-2, CAS3) following low dose administration  
of prostaglandin F2α……………………………………….…………..     47 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 
 
 
 
 
 
 
 
 
CHAPTER I 
 INTRODUCTION AND LITERATURE REVIEW 
History of the Corpus Luteum 
 The corpus luteum is a transient endocrine gland necessary for pregnancy 
in all mammalian species.  The corpus luteum was first anatomically described 
by Renier de Graaf in 1672 and the name, meaning “yellow body”, was coined by 
Marcello Malpighi in 1689.  Original research concluded that the corpus luteum 
played a role in endocrine function and secreted its products directly into the 
blood (1).  Studies conducted in rabbits supported the notion that the corpus 
luteum was a secretory gland involved in maintenance of pregnancy, as ablation 
of the corpora lutea from pregnant rabbits resulted in abortion of all embryos (2, 
3).  However, in pregnant rabbits, removal of the ovary and subsequent injection 
of luteal extract allowed for the maintenance of pregnancy (4).  The main 
secretory product of the corpus luteum was subsequently purified and named 
progesterone in 1934 (5, 6, 7).    
Progesterone is produced in copious amounts by the corpus luteum during 
the luteal phase of the estrous cycle.  The hormone acts on various tissues, and 
must be present in adequate amounts in order to establish and maintain 
pregnancy.  Reported functions of progesterone include the mitigating effects on 
uterine contraction, regulation of gene expression and protein secretion in the 
uterus, ovary and oviduct, effects on gonadotrophin releasing hormone and 
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prevention of follicle stimulating hormone and luteinizing hormone secretion (8, 9, 
10).  Approximately 6-13% of progesterone is transported in the blood plasma 
unbound and “free” while the rest is transported bound to plasma proteins 
including albumin, sex hormone blinding globulins, or corticosteroid binding 
globulins (11, 12).  Adequate levels of progesterone are essential for early 
maintenance and establishment of pregnancy (13).  
Introduction to Problem 
 Each year, millions of dollars are lost in the U.S. dairy and beef industries 
due to poor reproduction in the bovine.  A majority of these lost pregnancies 
occur between approximately days 14-30 of gestation (14).  There are several 
possible avenues that can lead to early embryonic mortality in the bovine:  
chromosomal abnormalities, failure of egg fertilization, failure of placental 
attachment, and a failure of maternal recognition of pregnancy (15).  A significant 
amount of early pregnancies lost are due to failure in maternal recognition of 
pregnancy (16).  The event of maternal recognition of pregnancy is denoted by 
the successful signaling between a conceptus and the ability to secrete adequate 
amounts of the cytokine interferon-τ to act on the uterus and prevent intrauterine 
pulsatile release of prostaglandin F2α and subsequent regression of the corpus 
luteum.  If the release of interferon-τ is too weak or secreted too late, 
prostaglandin F2α will be secreted from the uterus and result in luteolysis 
(regression of the corpus luteum), loss of adequate progesterone needed for 
maintenance of pregnancy and subsequent embryo loss.  Interferon-τ also acts 
on uterine epithelium to inhibit expression of estrogen receptors and subsequent 
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oxytocin receptors.  This prevents oxytocin mediated release of the luteolysin 
prostaglandin F2α (17).  There must be adequate amounts of the cytokine 
interferon-τ secreted from trophoblastic cells of the conceptus to trigger 
successful maternal recognition of pregnancy (18, 19).  Sufficient release of 
interferon-τ inhibits the release of prostaglandin F2α from the uterus and 
prevents regression of the corpus luteum, thus triggering maternal recognition of 
pregnancy.  
 The goal of this research study was to determine the effects of 
polyunsaturated fatty acids found in fish meal on luteal sensitivity and gene 
expression in response to low dose administration of prostaglandin F2α.  While 
administration of interferon-τ has been shown to improve pregnancy in some 
studies, this method requires individual animal attention at least twice a day 
between days 14-17 of pregnancy and is impractical with large dairy operations 
or range cows (20).  Dietary supplementation with omega-3 fatty acids may allow 
for a greater time period for an embryo to signal maternal recognition of 
pregnancy and prevent regression of the corpus luteum.  A small, slow 
developing embryo may not secrete adequate amounts of interferon-τ to prevent 
luteolytic pulses of prostaglandin F2α.  By reducing luteal sensitivity and 
responsiveness to prostaglandin F2α, this may supply a developing conceptus 
adequate time to secrete a strong enough signal of interferon-τ to successfully 
prevent regression of the corpus luteum and trigger maternal recognition of 
pregnancy.   
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Additionally, incorporating omega-3 fatty acids into the diet is a non-
invasive and cost effective way to potentially increase viable pregnancies in the 
bovine.  Supplementing with polyunsaturated fatty acids and allowing for 
incorporation into reproductive tissues may be a way to preserve the lifespan of 
the corpus luteum and prevent failure in maternal recognition of pregnancy.  
Bovine Estrous Cycle 
The estrous cycle of a mature cow is denoted by four distinct phases and 
is approximately 21 days in length (Figure 1). The beginning of the cycle (day 0) 
is denoted as estrus, or “standing heat”, a 12-18 hour period during which the 
female will demonstrate sexual behavior.  During this time, the cow will mount 
other females and stand to be mounted by herd mates or the bull.  During estrus, 
a dominant Graafian follicle will secrete high amounts of estradiol which 
stimulates the hypothalamus to release a surge of gonadotrophin releasing 
hormone and is also responsible for driving estrous behavior.  Subsequently, the 
release of gonadotrophin releasing hormone will stimulate the anterior pituitary 
gland to secrete a surge of luteinizing hormone and bring about ovulation.  
Ovulation, brought about by a surge in luteinizing hormone and rupture of the 
present Graffian follicle, will take place roughly 24-30 hours following the onset of 
estrus.  Concurrently, granulosa cells of ovarian follicles will secrete inhibin and 
prevent secretion of follicle stimulating hormone and development of new 
follicles. 
Following estrus, metestrus (days 1-5) is characterized by the initial 
development of the corpus hemorrhagicum and rising production of 
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progesterone.  Theca and granulosa cells are luteinized and differentiate into 
small and large luteal cells, respectively.  Levels of progesterone rise steadily 
while the corpus luteum matures and undergoes rapid angiogenesis.  
Additionally, a surge of follicle stimulating hormone occurs and begins the initial 
cohort of follicle development. 
Diestrus spans from days 6-17 of the estrous cycle and is designated by 
the presence of a mature corpus luteum.  During this phase, copious amounts of 
progesterone are secreted, and rapid growth and hypertrophy of cells within the 
corpus luteum continues. 
The last phase of the estrous cycle is called proestrus (days 18-24) and is 
characterized by uterine prostaglandin F2α induced regression of the corpus 
luteum and rapid decline of progesterone.  During proestrus, lack of 
progesterone allows for an increase in frequency and amplitude of follicle 
stimulating hormone and luteinizing hormone.  These hormones support 
development of a pre-ovulatory Graffian follicle and subsequent production of 
estrogen.  Once levels of estradiol reach a threshold concentration in the blood, 
this triggers a surge of luteinizing hormone from the anterior pituitary gland, 
resulting in ovulation and the beginning of the next estrous cycle.   
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Figure 1: Diagram of phases of estrus cycle and fluctuations of 
progesterone, estradiol, luteinizing hormone, and follicle stimulating 
hormone concentrations.  Image adapted from (21). 
 
The Corpus Luteum 
Formation of the corpus luteum occurs following ovulation.  Secretion of 
gonadotrophin releasing hormone from the hypothalamus will act on the anterior 
pituitary gland causing a surge of luteinizing hormone release.  Following the 
surge of luteinizing hormone, rupture of the Graafian follicle will occur and initiate 
the rapid cell reprogramming of granulosa and theca cells into small and large 
luteal cells.   
The corpus luteum is composed of several major cell types including small 
and large luteal cells (steroidogenic cells), endothelial cells, fibroblasts, pericytes, 
and various immune cells.  By volume, large luteal cells account for 
approximately 40% of the gland, while small luteal cells comprise approximately 
30% (22).  By cell number, large luteal cells account for approximately 4% of the 
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cells and small luteal cells account for nearly 20% of total cells (23). The corpus 
luteum is highly vascularized with up to 50% of the gland’s cells composed of 
endothelial cells that form blood vessels (24).  Pericytes, fibroblasts and various 
immune cells comprise the rest of the gland. 
Following ovulation, the process of luteinization begins.  Granulosa cells 
and theca cells reprogram into large and small luteal cells (25).  Prior to 
ovulation, granulosa cells that were once part of the dominant Graffian follicle 
predominantly produced estradiol (26).  After luteinization takes place, mid-cycle 
large luteal cells will secrete up to 80% of total progesterone (27).  Many genes 
once responsible for biosynthesis of estradiol remain constitutively expressed 
and are instead utilized for progesterone secretion (28).  While the transition from 
estradiol to progesterone synthesis takes place, luteal cells will migrate from the 
remnants of the ovulatory follicle to form the corpus luteum.  Additionally, 
extracellular matrix remodeling, activation of matrix metalloproteins 2 and 9, rapid 
neovascularization and breakdown of basement membrane occur to allow for the 
migration of cells forming the corpus luteum (29).  The developing corpus luteum 
is a hypoxic environment, with hypoxia-inducible factor 1 highly upregulated, 
causing stimulation of vascular endothelial growth factor expression and 
subsequent vascular growth (30).  The hypoxic environment during luteinization 
has been shown to increase progesterone output and increase protein 
expression levels of STARD1 and 3βHSD (31, 32).  During the hypoxic 
conditions while following ovulation, highly expressed levels of fibroblast growth 
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factor 2 and platelet derived growth factor in endothelial cells and pericytes drive 
neovascularization (33, 34).   
 The growth of the corpus luteum is due to both hypertrophy and 
hyperplasia of luteal cells (35).  Additionally, rapid angiogenesis occurs via 
expression of vascular endothelial growth factors and fibroblast growth factors.  
While the cells do increase in size as they grow from the beginning to mid luteal 
stage, mostly the growth of the corpus luteum is due to high upregulation of 
genes promoting the cell cycle, which causes an increase in cell number (36).  A 
significant amount of growth of the corpus luteum is due to an upregulation of the 
fibroblast growth factors heparin binding growth factors 1 and 2 (37). These 
growth factors directly result in angiogenesis.  Upregulation of mRNA for insulin-
like growth factors is also necessary for establishment of the corpus luteum and 
results in downregulation of luteolytic factors (38).   
  In the bovine, small luteal cells, large luteal cells, collagen, and 
fibroblasts will cohabitate the corpus luteum.  These cells become intermixed 
upon their formation into the mature corpus luteum (39).  Small luteal cells have 
a high number of receptors for luteinizing hormone with fewer number of these 
receptors found on large luteal cells (40).  Small luteal cells will respond to 
luteinizing hormone and will begin an intracellular signaling cascade leading to 
an increase in progesterone biosynthesis.  The luteinizing hormone receptor is a 
seven-helix transmembrane G-protein coupled receptor that initiates the GalphaS 
intracellular signaling cascade.  Adenylate cyclase is activated upon binding of 
ligand and will cause an increase in cAMP within the cells and ultimate activation 
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of protein kinase A (41).  Further downstream, the MAP (mitogen activated 
protein) kinase pathway will upregulate production of transcription factors c-fos 
and c-jun that promote growth within the corpus luteum (42).   
Progesterone Biosynthesis 
 The precursor to all steroid hormones is cholesterol (43).  While 
cholesterol can be synthesized de novo from acetate within most steroidogenic 
cells, the main source of cholesterol is from blood lipoproteins or cholesterol 
esters stored as lipid droplets within the cell.  Cholesterol is transported in the 
blood bound to either low or high density lipoprotein receptors.  These 
lipoproteins are internalized into the cell using specific low density lipoproteins or 
scavenger B1 receptor.  Once internalized, cholesterol is sorted from the 
lipoprotein and stored as lipid droplets or shuttled to the inner mitochondrial 
membrane by the transporter steroidogenic acute regulatory protein (STARD1), 
the rate limiting step in steroid biosynthesis.  Cholesterol is then converted to 
pregnenolone by the P450 side chain cleavage enzyme, CYP11A1.  
Pregnenolone is transported to the smooth endoplasmic reticulum where it is 
converted to progesterone by the enzyme 3βHSD.  The comprehensive pathway 
is depicted in Figure 2.   
 A mid-cycle corpus luteum will produce large quantities of the steroid 
hormone progesterone.  The surge of luteinizing hormone that induced ovulation 
also acts to stimulate luteal cells to produce progesterone (44).  Progesterone 
primarily acts on the endometrium to prepare the uterus for a potential 
pregnancy.  Progesterone also targets the mammary gland, brain, and is 
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considered luteoprotective and helps to prevent apoptosis of the corpus luteum 
(45, 46).  Additionally, progesterone prevents secretion of gonadotrophin 
releasing hormone from the hypothalamus and luteinizing hormone from the 
anterior pituitary (47).  Progesterone levels are detectable in the blood at 
approximately day 5 of the estrous cycle and will remain elevated until the 
beginning of luteolysis.  As the corpus luteum ages, steroid production drastically 
decreases at approximately day 17-20 following ovulation in the non-pregnant 
cow in response to the luteolytic effects of prostaglandin F2α (48). 
 
Figure 2: Representation of the steroidogenic pathway that takes place in 
luteal cells to produce progesterone.  Cholesterol sources include the 
bloodstream via low or high density lipoproteins or from cholesterol esters within 
the cell.  The rate limiting step of this pathway is transport of cholesterol into the 
mitochondrion inner leaflet by StAR protein, where it will then be cleaved to form 
pregnenolone by P450scc, and finally into progesterone by 3βHSD.  
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 In the bovine, adequate secretion of progesterone from the corpus luteum 
is necessary for 200 days of a 280 day pregnancy (49).  Upon fertilization and 
prior to implantation, the dam’s body must maternally recognize the pregnancy in 
order to keep the corpus luteum from regressing.  Adequate growth of the corpus 
luteum is crucial to prevent loss of early pregnancy.  Interferon tau is produced 
by trophoblastic cells of the developing conceptus.  Interferon tau will target the 
uterus and prevent pulsatile release of prostaglandin F2α, preventing the 
regression of the corpus luteum.  However, if the signal is too late or not strong 
enough, prostaglandin F2α will be released from the uterus causing the death of 
the corpus luteum, a subsequent drop in progesterone and termination of the 
pregnancy.  However, in the event of a successful pregnancy, the corpus luteum 
remains well vascularized and secretes copious amounts of progesterone.  The 
vascular endothelial growth factors presence helps to ensure proper perfusion of 
the corpus luteum of pregnancy until its function is replaced by the placenta (50, 
51).   
Luteolysis 
 When no pregnancy occurs, the corpus luteum will undergo 
regression.  The primary instigator of luteal regression is caused by 
prostaglandin F2α.  However, the detailed pathway controlling the onset of luteal 
regression is unknown.  There are two mechanisms of luteal regression: 
structural and functional.  Structural regression is denoted as a decrease in size 
of the gland while functional regression is the decrease and ultimate cessation of 
progesterone biosynthesis (52).  In the event no pregnancy occurs, a series of 
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pulses of prostaglandin F2α will be released from the uterus leading to 
regression of the corpus luteum (53).   
 The mechanism by which prostaglandin F2α acts on the corpus luteum is 
through binding of the FP receptor and activation of the seven helix G-protein 
coupled receptor and subsequent signaling cascade.  Upon binding to its 
receptor on large luteal cells, phosphatidylinositide phospholipase C (PLC) is 
activated leading to the cleavage of phosphatidylinositol 4, 5 bisphosphate (PIP2) 
and production of inositol 1, 4, 5 triphosphate (IP3) and diacylglycerol (DAG).  
The IP3 present will diffuse to the smooth endoplasmic reticulum.  Binding of the 
IP3 receptor allows for an intracellular release of Ca2+.  Increased Ca2+ within the 
cell and DAG located at the plasma membrane stimulate the activity of Ca2+ 
dependent protein kinase C (PKC) (54).  The actions of PKC mediate multiple 
luteolytic actions of prostaglandin F2α in large luteal cells.  Protein kinase C can 
negatively impact steroidogenesis (55), cholesterol liberation (56), and 
maintenance of the extracellular matrix (57).   
 Functional luteolysis is defined as the inability of the corpus luteum to 
secrete adequate amounts of progesterone.  Following intramuscular 
administration of prostaglandin F2α, decline in progesterone can take place 
within four to eight hours (58).  There are many mechanisms by which 
prostaglandin F2α may bring about a loss in luteal ability to secrete 
progesterone.  Prostaglandin F2α signaling and downstream activation of PKC 
can alter posttranslational modification of key steroidogenic proteins (59, 60).  
During luteolysis, downregulation of genes involved with cholesterol uptake takes 
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place while genes involved in production of prostaglandin F2α increased (61).  
Several studies indicate that prostaglandin F2α can autoregulate its synthesis by 
affecting liberation and conversion of membrane phospholipids into arachidonic 
acid, the precursor molecule of prostaglandin F2α (62).  Additionally, a decrease 
in uptake of cholesterol or transport of cholesterol into the cell or across the 
mitochondrial membrane may also negatively impact progesterone biosynthesis.  
Prostaglandin F2α causes a decrease in mRNA expression of the low density 
lipoprotein receptor (LDLR) yet functionally the corpus luteum may still remain 
capable of adequate progesterone secretion (63).  This suggests that 
prostaglandin F2α may not affect uptake of cholesterol during spontaneous 
luteolysis.  However, prostaglandin F2α may impact transport of cholesterol 
across the mitochondrial membrane and causes a decrease in STARD1 mRNA 
and translated protein levels (64, 65).  During luteolysis, there is also a loss in the 
mRNA expression level of other key players involved in progesterone 
biosynthesis such as 3βHSD and CYP11A1.  Loss of these enzymes may result 
in a mitigated output in progesterone biosynthesis.   
 Structural luteolysis is characterized by the onset of programmed cell 
death, emigration of various white blood cells, loss of gland structure and 
vascularization.  The phagocytosis by leukocytes occurs and dead luteal cells are 
removed.  Immune cell presence within the corpus luteum fluctuates throughout 
the estrous cycle and is an important driver in luteolysis (66).  Various cytokines 
are secreted by white blood cells driving ultimate regression of the gland and 
additional attraction of other leukocytes such as macrophages and T-
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lymphocytes (67).  Expression of the major histocompatibility complex (MHC) 
class II molecules are important in mediating emigration of T-lymphocytes during 
luteolysis (68).  T-lymphocytes further drive apoptosis of luteal cells through 
activation of Fas ligand mediated programmed cell death (69).  The presence of 
macrophages increases drastically during the transition from an early to late 
stage corpus luteum, leading to an increase in cytokine production (70, 71).  
Secretion of pro-inflammatory cytokines such as tumor necrosis factor α, 
interferon γ, interleukin-6, and interleukin-1b play a major role in attracting 
immune cells to the corpus luteum during luteolysis leading to structural 
regression of the gland (72, 73). 
 Luteal exposure to prostaglandin F2α will cause an intracellular signaling 
cascade that leads to intrinsically mediated apoptosis (74).  In a healthy cell, the 
protein B cell lymphoma-2 (BCL-2) will bind to the BCL-2 associated X protein 
(BAX), preventing apoptosis.  However, prostaglandin F2α will cause an increase 
in BAX expression, altering the ratio of BAX/BCL-2 proteins.  BAX protein will 
then act on the mitochondrial membrane and cause an increase in membrane 
permeability and subsequent release of cytochrome C leading to apoptosis (75).   
Prostaglandin F2α is a potent vasoconstrictor and will cause a decrease in 
vasculature diameter within the corpus luteum, leading to ischemia and ultimately 
tissue death (76).  During the late stages of the luteal phase, the expression 
rates of insulin-like growth factors are upregulated, suggesting that these growth 
factors (once involved in luteotropic activity) play a role in regression of this gland 
(77).  During regression of the corpus luteum, high levels of local cortisol 
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secretion from adrenocortical are observed and can play a role in driving the 
process of structural luteolysis.  High levels of cortisol cause a drastic loss in 11 
beta-hydroxysteroid dehydrogenases, enzymes necessary for luteal maintenance 
and prevention of apoptosis (78).  Upon the onset of luteal regression, genes 
once involved in extracellular matrix establishment (gelatinases and 
metalloproteinases) become downregulated, leading to a loss in structure 
surrounding luteal cells (79).  In a corpus luteum that is undergoing regression, 
the mRNA of key steroidogenic genes needed to properly synthesize 
progesterone are drastically downregulated (80).  Even though no clear 
pathways have been linked to the onset of luteal regression, many individual 
genes that concurrently become downregulated lead to death of this gland.   
Gene Expression During  
Luteal Regression 
Immediate-Early gene expression.  Regression of the corpus luteum is 
directly correlated to exposure of luteal tissue to the endogenous luteolysin 
prostaglandin F2α.  The luteolytic effects of prostaglandin F2α will bring about a 
rapid change in immediate early gene signaling and expression.  There are a 
multitude of downstream affects mediated by immediate early gene activation 
(81, 82).  The transcription factors c-FOS and NR4A1 have been suggested to be 
critical mediators of apoptotic signaling pathways, while also negatively affecting 
downstream steroidogenic gene expression (83, 84). The activator protein-1 (AP-
1), a transcription factor complex activated by c-FOS and JUN proteins, has been 
shown to be involved in prostaglandin F2α induced luteolysis (85).  Both 
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pharmacological and physiological doses of prostaglandin F2α administered to 
animals cause an increase in immediate early gene mRNA (86).   
NR4A1 is a part of the NR4A family, and is one of three homologues.  The 
NR4A family has been shown to be involved in metabolism, survival, apoptosis, 
and differentiation in several cell types (87, 88).  In the pregnant rat, NR4A1 
(Nur77 protein) was shown to be involved in conversion of progesterone into its 
non-active form, 20α-hydroxyprogesterone (89).  Luteal regression induced by 
prostaglandin F2α causes rapid increases in NR4A1 mRNA expression levels 
(90).  Increases in NR4A1 transcript levels and subsequent Nur77 protein levels 
may be important drivers of apoptosis in steroidogenic cells.  Nur77 has been 
shown to interact with the retinoid X receptor (RXR) and further downstream 
members of the BCL-2 family to bring about apoptosis (91).   
The immediate early gene c-FOS belongs to a family with four other 
members that encode for proteins that interact with the JUN family of proteins 
and together form the AP-1 transcription factor complex.  The AP-1 transcription 
factor complex regulates the transcription of several genes following its 
activation.  Prostaglandin F2α is known to activate the MAP kinase signaling 
cascade, which directly regulates activation of the AP-1 complex.  Activation of c-
FOS by prostaglandin F2α occurs via activation of the PKC-dependent MAP 
kinase signaling pathway (92).  Influences of the luteolysin prostaglandin F2α 
cause changes in immediate early gene expression, ultimately leading to 
induction of apoptosis and luteal regression. 
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Luteotropic gene expression.  The expression of any gene that is 
directly involved in cholesterol transport, progesterone biosynthesis or 
perpetuation of the lifespan of the corpus luteum is considered “luteotropic”.  
Luteotropic genes are upregulated at the beginning of the luteal phase and their 
expression is maintained with stimulation of luteinizing hormone and the 
luteoprotective effect of progesterone (93, 94).   
 The low density lipoprotein receptor (LDLR) and scavenger B1 receptor 
(SR-B1) work concurrently to bind the respective lipoprotein in the blood and 
result in the internalization of cholesterol.  Most cholesterol is internalized via 
clathrin mediated endocytosis of the LDLR or selective uptake of the SR-B1 
receptor (95).  Upon exposure to prostaglandin F2α, expression of LDLR and 
SR-B1 decrease, resulting in a reduction in cholesterol uptake in steroidogenic 
cells and subsequent loss in progesterone secretion.  
STARD1 is a protein responsible for shuttling cholesterol into the 
mitochondrial membrane and is the rate limiting step in progesterone 
biosynthesis.  The STARD1 protein contains a StAR-related lipid transfer 
(START) domain involved in the binding of cholesterol (96).  Recent reports in 
the literature suggest the mechanism by which cholesterol is shuttled into the 
mitochondrial matrix does not involve the translocator protein (TSPO).  Instead, a 
newly proposed model suggests that cholesterol is transported into the inner 
mitochondrial membrane mediated mainly by STARD1 protein while being 
regulated by voltage-dependent anion-selective channel protein 2 (VDAC2) (97).  
STARD1 expression is crucial in maintaining progesterone secretion within luteal 
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steroidogenic cells.  Luteolytic pulses of prostaglandin F2α will drastically 
decrease STARD1 mRNA and protein levels, further slowing the rate-limiting 
step in progesterone biosynthesis and decreasing progesterone output.   
The cytochrome p450scc enzyme (CYP11A1) is responsible for conversion 
of cholesterol into the progesterone precursor molecule, pregnenolone.  
Pregnenolone travels to the smooth endoplasmic reticulum where it is converted 
to progesterone by 3βHSD protein.  Reports in the literature suggest that 
mitochondrial docking with the endoplasmic reticulum is necessary for 
progesterone biosynthesis (98, 99).  Knockdowns in genes such as cytoskeletal 
polymers or those facilitating mitochondrial fusion were critical to prevent 
unimpaired steroidogenesis (100).   
Expression of the aforementioned genes and subsequent proteins are 
critical in driving cholesterol uptake and progesterone biosynthesis within the 
corpus luteum.  These proteins work together to promote longevity of the corpus 
luteum. 
Luteolytic gene expression.  Prostaglandin F2α is synthesized and 
released from endometrial cells in the uterus. During the late stages of the estrus 
cycle, prostaglandin F2α is transported to the ovary via the extensive vascular 
network of the uterio-ovarian plexus and the prostaglandin transport protein 
(101).  The prostaglandin F receptor (FP) is a G-protein coupled receptor and is 
responsible for binding prostaglandin F2α.  Upon binding of this hormone, an 
intracellular signaling cascade is triggered that ultimately leads to both functional 
and structural regression of the corpus luteum.  The precursor molecule of 
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prostaglandin F2α is arachidonic acid, an omega-6 fatty acid.  This fatty acid is 
converted to prostaglandin F2α by the enzymes PGHS1 and PGHS2.  
Prostaglandin F2α has been reported to increase prostaglandin-endoperoxide 
synthase 2 (PGHS2) expression in the corpus luteum, acting as a positive 
feedback that drives further regression of the corpus luteum (102).   
Apoptotic gene expression.  Following the induction of luteolysis, 
expression of the apoptotic genes BAX, BCL-2, and CAS3 are altered in 
response to prostaglandin F2α signaling, bringing about an intrinsic mechanism 
of apoptosis in a late stage corpus luteum.  In the primate, a corpus luteum of 
early pregnancy will have a high expression level of BCL-2, a pro survival gene, 
and a low expression level of BAX, a pro-apoptotic gene (103, 104).  However, a 
regressing corpus luteum will conversely have a low expression of BCl-2 but a 
high expression level of BAX.  A regressing corpus luteum will express 
increasing levels of CAS3 mRNA during prostaglandin F2α induced luteolysis 
(105, 106).  Bovine luteal cells exposed to prostaglandin F2α will have a 
significant increase of p53 protein, BAX, and CAS3 mRNA in the subsequent 24 
h period following exposure to this luteolysin (107).  Increase in p53 activity can 
lead to an abundance of reactive oxygen species within the cells, further driving 
apoptosis (108).  It is hypothesized that fish meal supplementation will help 
prevent a decrease in BCL-2 expression and attenuate BAX and CAS3 
expression following exposure to low doses of prostaglandin F2α. 
Immune cell populations will fluctuate throughout the lifespan of the 
corpus luteum.  During luteolysis, there is an emigration of macrophages and 
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other phagocytic white blood cells.  A non-functioning cell will be phagocytized 
during this immigration of immune cells.  Newly present immune cells will secrete 
cytokines such as interleukin-1β and tumor necrosis factor α, causing recruitment 
of more immune cells to the corpus luteum (109).   
Apoptosis can be brought about by an extrinsic mechanism most likely 
mediated by Fas ligand activation (110, 111).  Immune cell emigration during a 
late stage corpus luteum and their secretion of tumor necrosis factor α and 
interferon γ can activate Fas mediated apoptosis (112).  Activated Fas will bind to 
the Fas associated death domain protein (FADD) and will lead to downstream 
activation of caspase 8 and further cleavage of effector caspases leading to 
apoptosis. 
Omega-3 Polyunsaturated Fatty Acids 
Polyunsaturated fatty acids (PUFA) have been shown to positively 
influence reproduction in the bovine (113, 114).  Nutrition, specifically energy 
availability, are essential to reproductive success in the bovine (115).   There are 
two essential fatty acids that must be acquired through the diet, the omega-6 
fatty acid linolenic acid (LA) and the omega-3 α-linolenic acid (ALA).  Omega-3 
fatty acids are characterized by the presence of a double bond at carbon three 
from the methyl end of the acyl chain of each molecule.  Long chain omega-3 
fatty acids can be synthesized from the short chain ALA through the action of 
elongases and desaturases (116).  Several omega-3 fatty acids are potentially 
beneficial for reproduction including ALA, eicosapentanoic acid (EPA) and 
docosahexanoic acid (DHA).  Both EPA and DHA have been shown to 
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incorporate into reproductive tissues as well as benefit luteal, ovarian, and 
uterine function in the bovine. (117, 118, 119).   
At the level of the uterus, supplementation with PUFA has been shown to 
affect prostaglandin F2α secretion (120, 121).  A higher ratio of omega-3 to 
omega-6 fatty acids in cultured bovine endometrial cells resulted in attenuated 
secretion of prostaglandin F2α (122).  Simultaneously affecting prostaglandin 
F2α secretion at the uterus in addition to altering sensitivity of the corpus luteum 
to the luteolytic effects of prostaglandin F2α may be an effective way to ensure 
maternal recognition of pregnancy and prevent early embryonic mortality.   
Fish oils found in cold water fishes are rich in the omega-3 fatty acids EPA 
and DHA.  Previous studies in our laboratory have shown these fatty acids to 
alter mobility of the FP receptor as well as the structure of lipid microdomains in 
bovine luteal tissue both in vitro and in vivo (123).   Therefore, dietary 
supplementation of omega-3 fatty acids could decrease luteal sensitivity to 
prostaglandin F2α (124, 125).  Maintaining functional production of progesterone 
in addition to a loss in sensitivity to the luteolytic effects of prostaglandin F2α can 
lead to a prolonged lifespan of the corpus luteum following intrauterine infusion of 
prostaglandin F2α.  
Specific Aims 
This study examined dietary fish meal supplementation on changes in 
luteotropic, luteolytic, and apoptotic gene expression in the bovine corpus luteum 
following low dose administration of PGF2α.  Luteal tissue from mid-cycle corpus 
luteum of non-pregnant, cycling cows supplemented with either corn gluten meal 
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or fish meal was biopsied following treatment with saline or low doses of PGF2α.  
It was hypothesized that omega-3 fatty acids in fish meal may lead to a global 
upregulation of luteotropic genes as well as an attenuated expression of luteolytic 
and apoptotic genes compared to those observed in corn gluten meal 
supplemented animals following intrauterine infusion of PGF2α.  Furthermore, 
immediate early gene expression was expected to be attenuated in animals 
supplemented with fish meal following treatment with PGF2α compared to those 
supplemented with corn gluten meal.   
Long-term goals of this study were to mitigate the effects of PGF2α on the 
corpus luteum by supplementing animals with omega-3 fatty acids in order to 
prevent premature luteolysis during early pregnancy.  This may be achieved from 
dietary supplementation of omega-3 fatty acids found in fish meal and 
subsequent incorporation of these fatty acids into the biological membranes of 
reproductive tissues. 
Aims, Research Questions and Hypotheses 
A1 Examine steady-state mRNA expression in the bovine corpus luteum 
obtained from animals supplemented with fish meal or corn gluten meal. 
 
Q1  What are the effects of omega-3 fatty acids from fish meal on luteotropic 
gene expression (STARD1, CYP11A1, 3βHSD, LDLR)? 
 
H1 Cows supplemented with fish meal will exhibit a higher expression level of 
steroidogenic mRNA expression than animals fed corn gluten meal. 
 
Q2 What are the effects of omega-3 fatty acids from fish meal on 
steady- state expression of apoptotic (BAX, BCL-2, CAS3) and 
luteolytic (PGHS2, PTGFR)? 
 
H2 Luteal tissue obtained from cows supplemented with fish meal will 
have reduced steady-state levels of apoptotic and luteolytic mRNA. 
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A2 Examine luteotropic, luteolytic, apoptotic, and early immediate 
steady-state mRNA levels following intrauterine infusion of 
PGF2α in animals supplemented with fish meal to those 
supplemented with corn gluten meal. 
 
Q1 What are the effects of omega-3 fatty acids from dietary 
supplementation of fish meal on luteotropic gene expression 
(STARD1, CYP11A1, 3βHSD, LDL)? 
 
H3 Cows supplemented with fish meal will have a higher steady-state 
level of STARD1, CYP11A1, 3βHSD, and LDLR mRNA following 
intrauterine infusion of PGF2α as compared to cows supplemented 
with corn gluten meal. 
 
Q2 What are the effects of dietary omega-3 fatty acid supplementation 
on luteolytic gene expression (PGHS2, PTGFR)? 
 
H4 Animals supplemented with fish meal will have an attenuated level of 
luteolytic mRNA expression of PGHS2 and PTGFR following 
intrauterine infusion of PGF2α compared to animals supplemented 
with corn gluten meal. 
Conclusion 
Early pregnancy termination in the bovine contributes significantly to 
substantial monetary losses in the beef and dairy industries every year.  Within 
the first 30 days of pregnancy, up to 30% of embryos die, impacting milk and 
meat production due to a decrease in healthy births (126).  There are several 
causes of early embryonic death and one potential cause is a miscommunication 
between the developing embryo and maternal uterine environment, resulting in 
regression of the corpus luteum and termination of the pregnancy. 
 The lifespan of the corpus luteum, from its formation to its eventual 
demise is controlled by a plethora of changes in gene expression.  It is crucial to 
analyze the gene expression rates and changes over the entire lifespan of the 
gland and properly cluster groups of gene expression.  In order to shed light on 
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pathways that are not known, such as luteolysis, transcriptome analysis and 
proteomic analysis must be monitored as well as levels of hormones and their 
actions on each type of cell.  It is necessary to ensure that gene expression 
differences between small and large luteal cells are taken into consideration 
throughout the lifespan of the corpus luteum as well as during pregnancy.  Since 
there are different mechanisms to keep the corpus luteum in a luteotropic state 
both during the secretory phase as well as during pregnancy, the mechanisms 
individually controlling the regression of the corpus luteum during these separate 
events could differ.  This study examined the effects of omega-3 fatty acid 
supplementation on bovine luteal cell sensitivity to repeated intrauterine doses of 
prostaglandin F2α.  Understanding the direct mechanisms involved in luteolysis 
and early embryonic mortality may provide insight for non-invasive, cost effective 
interventions to increase pregnancy rate in the bovine. Incorporation of omega-3 
fatty acids from fish meal into luteal tissue of breeding females may increase the 
chance of successful pregnancy. 
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CHAPTER II 
 METHODOLOGY 
Animal Husbandry and Luteal  
Biopsy Collection 
All animal procedures included in this study were approved by the 
Colorado State University institutional animal care and use committee (Approval 
# 13 - 4440A). Beef cows of mixed breed were purchased from a local sale barn 
and housed at the Colorado State University Animal Reproduction and 
Biotechnology Laboratory in Fort Collins, Colorado.  Transrectal ultrasonography 
was used to scan reproductive organs for pregnancy and anatomical 
abnormalities. Any cow with anatomical abnormalities or pregnant was removed 
from the study.  
 Cows were stratified by body weight and randomly assigned to either corn 
gluten or fish meal supplementation.  Cows were individually fed an isocaloric 
and isonitrogenous ration consisting of 95% mixed-grass hay and 5% 
supplement.  Animals were supplemented for approximately 60 days, providing 
adequate time for the omega-3 fatty acids found in fish meal to become 
incorporated into blood and reproductive tissues.  Each week, body weights were 
recorded and jugular blood samples were collected to monitor changes in plasma 
fatty acid composition during the supplemental period.  Gas chromatography-
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mass spectroscopy was used to monitor these changes in plasma fatty acid 
composition and data have been reported elsewhere (127). 
 
 
 
Figure 3: Schematic diagram of dietary supplementation and experimental 
design. Cows were supplemented with corn gluten meal or fish meal for 
approximately 60 days. Cows were administered injections of prostaglandin F2α 
on day 35 and 50 synchronize estrous cycles. On day 10–12 following estrus, 
cows were treated with intrauterine infusions of saline (four doses at 6-h 
intervals) or prostaglandin F2α (two doses at 12 h intervals). Intrauterine infusion 
and luteal biopsies performed at 30 min post-infusion. 
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Table 1: Dietary supplementation ingredients, chemical composition, and fatty 
acid profile. 
Item Experimental Diet 
 Corn Gluten Meal Fish Meal 
Dry Matter Intake (%) 5 5 
Ingredient of Pelleted 
Supplement (%) 
0 60.0 
Corn Gluten Meal 59.3 0 
Wheat midds 19.2 17.4 
Wheat, ground 7.3 7.8 
Limestone 7.4 7.4 
Molasses Cane 4.0 4.0 
Salt  1.3 1.3 
Soybean oil-mixer 0.25 0.8 
Magox 0.3 0.3 
Monocal 16 21 0.25 0.25 
ZnSO4 0.2 0.2 
Se 0.1 0.1 
MnSO4 0.1 0.1 
CuSO4 0.1 0.1 
Vitamin A 30/3 0.1 0.1 
Vitamin E 125 0.02 0.02 
Vitamin D 0/30 0.02 0.01 
Ranch-o-dine 0.02 0.02 
Chemical Analysis    
Crude Protein (%) 39.8 40.1 
Degradable Intake 
Protein (%) 
29.5 29.9 
Undegradable Intake 
Protein (%) 
33.7 34.2 
Total Digestible 
Nutrients (%) 
68.8 69.6 
Crude Fat (%) 3.0 3.5 
Fatty Acid Composition of Supplement (wt %)  
Palmitic Acid  14.3 26.4 
Palmitoleic Acid 1.5 8.7 
Stearic Acid 17.8 4.6 
Oleic Acid 38.8 12.5 
Linoleic Acid 2.2 11.6 
Alpha-Linoleic Acid 2.2 2.5 
Arachidonic Acid <0.5 1.1 
Eicosapentanoic Acid <0.5 9.0 
Docosahexaenoic Acid  <0.5 8.9 
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 Estrous cycles were synchronized using a 25 mg intramuscular dose of 
prostaglandin F2α (Lutalyse®) at day 35 and again at day 50.  Cows were 
observed for estrous behavior at dawn and dusk for a minimum of 30 min.  
Approximately 10 – 12 days following observed estrus after the second 
prostaglandin F2α injection, cows were randomly assigned to receive either four 
doses of 0.25 mL saline or two doses of 0.5 mg of prostaglandin F2α in 0.25 mL 
saline.  Intrauterine infusions were administered into the uterine horn ipsilateral to 
the ovary bearing the corpus luteum.  Animals assigned to prostaglandin F2α 
treatment received two intrauterine infusions of prostaglandin F2α at the first (0 
h) and third (12 h) time points and saline given at the second (6 h) and fourth (18 
h) time points.  
 Luteal biopsies were taken from the corpus luteum to determine steady-
state mRNA levels of luteotropic, luteolytic, apoptotic, and early immediate 
genes.  Luteal biopsies were collected 30 min post-intrauterine infusion using 
transvaginal ultrasonography.  Prior to each luteal biopsy, a 3.5 mL epidural 
injection of 2% lidocaine hydrochloride was administered to induce a local 
anesthesia.  An Aloka 500 V ultrasound machine equipped with 5 MHz convex-
array transducer was used to visualize the ovary and the corpus luteum.  The 
ovary containing the corpus luteum was extracted to the vaginal vault and the 
gland was positioned along a projected needle path.  Luteal samples were 
collected using an 18-guage needle that passed through the vaginal wall and 
punctured the corpus luteum, taking 3-7 mg of tissue upon triggering the spring-
loaded needle.  Collected luteal samples were washed with sterile PBS to 
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remove blood or ovarian tissue and placed in a 1.7 mL Eppendorf tube.  Tissue 
samples were snap frozen in liquid nitrogen and stored at -80˚C until subjected to 
RNA isolation.  
Total Ribonucleic Acid Extraction and 
Complimentary Deoxyribonucleic 
Acid Synthesis 
 Total RNA was isolated from frozen tissue using the TRIzol™ Plus RNA 
Purification Kit.  In brief, tissue was homogenized on ice in 100 µL of TRIzol 
reagent.  Following homogenization, an additional 900 µL of TRIzol was added 
and allowed to incubate for 5 min at room temperature before adding 200 µL of 
chloroform.  Samples were vortexed and incubated for an additional 3 min. 
Samples were then subjected to centrifugation at 12,000 x g for 15 minutes at 
4˚C.  The aqueous phase was collected and transferred to a new 1.7 mL 
Eppendorf tube.  An equal volume of 70% ethanol was added to each sample 
and vortexed.  Samples were loaded onto spin columns and centrifuged at 
12,000 × g for 15 sec to bind RNA to membranes.  After binding, a series of 
washing were performed.  A volume of 700 µL of Wash buffer I was added to 
spin column and centrifuged at 12,000 x g for 15 sec.  Next, 500 µL of Wash 
Buffer II was used to wash each sample.  Samples were then centrifuged at 
12,000 x g for 15 sec at room temperature.  The 500 µL wash step with Wash 
Buffer II and subsequent centrifugation at 12,000 x g was repeated.  Bound RNA 
to membranes was dried for 2 min at room temperature and then eluted into a 
collection tube with 30 µL of nuclease free water for 2 min.  RNA quantification 
was completed using Qubit™ RNA HS Assay Kit purchased from ThermoFisher 
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Scientific.  Samples were stored at -80˚C until subjected to reverse transcription 
reaction.  
Following RNA extraction and quantification, 1 µg total RNA was reverse 
transcribed into cDNA using QuantiTect Reverse Transcription kit supplied by 
Qiagen.  Genomic DNA was removed from each sample by adding 2 µL genomic 
DNA wipeout buffer.  RNA was diluted using nuclease free water to a final 
volume of 14 µL.  Complimentary DNA was synthesized using a Bio-Rad T100 
PCR Thermal Cycler.  Samples were then incubated for 2 min at 42˚C.  Next, 1 
µL of RT enzyme, 4 µL of 5x RT buffer, and 1 µL of RT primer mix was added to 
the RNA samples.  Samples were incubated at 42˚C for 30 min and QuantiScript 
reverse transcriptase enzyme inactivated by incubating at 95˚C for 3 min.  
Following synthesis of cDNA, samples were stored at -80˚C until used in qPCR.   
Primer Design and Optimization 
Quantitative PCR was completed for each gene using bovine specific 
primers designed from mRNA sequences accessed from the NCBI nucleotide 
database.  Primer3 was used to generate primer pairs for each gene.  All gene 
names, primer sequences, product sizes, and efficiencies are listed in Table 2.  
Primer optimization was completed for each gene by using 10-fold serial dilutions 
of template and a standard curve generated to determine primer efficiency.  
Primer efficiency standard curves are shown in Appendix B.   
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Table 2: Gene name, primer sequences, accession numbers, product length and efficiencies. 
 
Gene Gene Name Forward Sequence Reverse Sequence Accession No. BP Effic. 
ACTB Beta-actin TTCCAGCAGATGTGGATCAG AGCCATGCCAATCTCATCTC NM_173979.3 154 2.1 
STARD1 Steroidogenic acute regulatory protein CAGCAGAAGGGTGTCATCAGA GAGAGGACCTGGTTGATGATG NM_174189 152 1.9 
LDLR Low density lipoprotein receptor GCAGCTCCCACCTCTAACT AGGGAACCAGAACGAAAGT NM_001166530.1 149 2.1 
CYP11A1 
Cholesterol 
sidechain cleavage 
enzyme 
AGGCAGAGGGAGACATAAGCA GTGTCTTGGCAGGAATCAGGT NM_176644 156 2.2 
3βHSD 3β-Hydroxysteroid Dehydrogenase CCAAGCAGAAAACCAAGGACTG AATGTCCACGTTCCCATCATTG NM_174343.3 110 1.8 
FOS FBJ Murine Osteosarcoma GAATCTGAGGAGGCCTTCACC TCAGCCTTCAGCTCCATGC NM_182786.2 103 2.0 
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Gene Gene Name Forward Sequence Reverse Sequence Accession No. BP Effic. 
NR4A1 
Nuclear receptor 
subfamily 4 group A 
member 1 
GTTCGAGGACTTCCAGGTGT AGAGCAGGGACTGCCATAGT NM_00107591 103 1.6 
PGHS2 
Prostaglandin-
endoperoxide 
Synthase 2 
CATGATGTTCTTTGTTGGCATT GCGAATTCCAACTTTCCATC NM_174445 154 2.2 
PTGFR Prostaglandin F Receptor TGACAGTGGGAATCTTATCGA CTATAGTTCCATTGATGAGGT NM_181028 153 1.7 
BAX BCL-2 Associated X TCTGACGGCAACTTCAACTG TCGAAGGAAGTCCAATGTCC NM_173894.1 135 2.1 
BCL-2 B-cell lymphoma 2 TTTGCTTCAGGGTTTCATCC ATCCTCTGCAGCTCCATGTT NM_001166486.1  147 2.0 
CAS3 Caspase 3 TCAGTCAGTTGGGCACTCTG CACACCCGTAGCTGTGAAGA  NM_001177840.1  144 1.9 
Table #2, continued 
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Quantitative Polymerase Chain Reaction 
All qPCR reactions were completed in duplicate for each gene of interest, 
along with the reference gene β-Actin.  In brief, 5 µL of QuantiTect SYBR Green, 
100 nM of each primer, 5 ng of cDNA, and nuclease free water to a total volume 
of 10 µL were combined on a 384 well PCR plate. Reaction conditions were 
carried out using a Bio Rad CFX384 real-time PCR system using the following 
reaction conditions.  Assays were carried out beginning with an enzyme 
activation at 95˚C for 15 min followed by 40 cycles of denaturation (94˚C for 15 
sec), annealing (60˚C for 30 sec) and amplification (72˚C for 30 sec).   
Dissociation curves for each target product were generated and melting 
temperatures were noted to ensure single amplification.  A negative control that 
did not include cDNA template was completed for each gene and included in 
each assay. 
Statistical Analysis 
 Statistical analysis of steady-state mRNA data was completed using the 2 
-ΔCq method as described by Livak (128) to determine fold change of each gene 
in relation to the reference gene β-Actin.  Data was transformed using the 
Shapiro-Wilk test for normality prior to statistical analysis.  Statistical model 
included treatment, time, treatment x time, and cow considered as a random 
variable in the model.  Data was analyzed using a 2-way ANOVA and 
calculations completed in SAS using PROC MIXED with repeated measures. 
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CHAPTER III 
 RESULTS 
Immediate-Early Genes Steady-State 
Messenger Ribonucleic 
Acid Expression 
 Luteal biopsies were taken 30 min following intrauterine infusions of 
prostaglandin F2α or saline to determine the effects of corn gluten meal or fish 
meal supplementation on steady-state mRNA levels of immediate early genes of 
interest.  Figure 4 illustrates changes in immediate early gene expression of FOS 
and NR4A1.  There was a main effect of treatment and time on steady-state 
mRNA expression of these genes (P < 0.05).  Dietary supplementation had no 
effect on FOS and NR4A1 expression in animals treated with saline (P > 0.05). In 
corn gluten meal supplemented animals that received two doses of prostaglandin 
F2α, there was a significant increase in both FOS and NR4A1 at the 0 and 12 h 
time points compared to animals that received saline (P < 0.05).  However, at 6 
and 18 h time points where prostaglandin F2α was not administered, there were 
no differences in FOS or NR4A1 steady-state mRNA (P > 0.05).  Within fish meal 
supplemented animals, there was no difference in immediate early steady-state 
mRNA levels following intrauterine infusion with prostaglandin F2α in either 
regressed or non-regressed corpora lutea (P > 0.05).  However, there was an 
increase in FOS and NR4A1 following prostaglandin F2α administration (P < 
0.05).   
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Figure 4: Effect of corn gluten meal or fish meal supplementation on 
immediate early steady-state mRNA expression following low dose 
administration of prostaglandin F2α.  Cows were administered four 
intrauterine infusions of 0.25 mL saline or two intrauterine infusions of 0.5 mg 
prostaglandin F2α between day 10 and 12 following a synchronized estrus. Cows 
assigned to prostaglandin F2α treatment were administered prostaglandin F2α at 
the first (0 h) and third (12 h) infusion and saline at the second (6 h) and fourth 
infusion (18 h).  Steady-state mRNA expression of FOS and NR4A1. Animals 
supplemented with corn gluten meal (open bar; n = 6) or fish meal (closed bar; n 
= 5) and infused with four doses of saline. Animals supplemented with corn 
gluten meal (regressed; dotted bar; n = 10) or fish meal (regressed; diagonal bar; 
n = 5; non-regressed gray bar; n = 6) following intrauterine infusions of 
prostaglandin F2α . Within time, means with different lettersabc differ significantly 
within treatment (P < 0.05) 
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Luteotropic Genes Steady-State 
Messenger Ribonucleic 
Acid Expression 
 Biopsies taken at each time point were used to determine steady-state 
mRNA levels of luteotropic gene expression following intrauterine infusions of 
either saline of prostaglandin F2α.  Dietary supplementation did not affect relative 
gene expression in LDLR, STARD1, CYP11A1, 3βHSD regardless of 
supplementation (P > 0.05) in cows that were administered four doses of saline.   
 Changes in steady-state mRNA expression for LDLR are denoted in 
Figure 5.  There was a main effect of treatment and time on steady-state mRNA 
expression for LDLR (P < 0.05).  Steady-state expression of LDLR mRNA was 
decreased in corn gluten meal supplemented animals in response to 
prostaglandin F2α at the 0 h time point when compared to saline treated animals 
(P < 0.05).  At each subsequent time point (6, 12, and 18 h), there was a 
consistent decrease in LDLR (P < 0.05).  There was a decrease in steady-state 
LDLR mRNA levels at both 6 and 18 h time points for cows supplemented with 
fish meal that had a regressed corpus luteum when compared to saline treated 
animals (P < 0.05).  Additionally, cows supplemented with fish meal that retained 
a non-regressed corpus luteum had a decrease in LDLR steady-state mRNA 
levels at 6, 12, and 18 h time points compared to saline infused animals (P < 
0.05).   
 Changes in luteal steady-state STARD1 mRNA expression in response to 
saline and prostaglandin F2α are shown in Figure 6.  There was a main effect of 
treatment and time on steady-state mRNA expression for STARD1 (P < 0.05).  
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Luteal steady-state mRNA expression of STARD1 was decreased in corn gluten 
meal supplemented cows treated with two doses of prostaglandin F2α as 
compared to saline treated control cows.  Fish meal supplemented cows that 
retained a non-regressed corpus luteum following administration of prostaglandin 
F2α had a decrease in STARD1 mRNA expression at the 6 h time point 
compared to other treatment groups (P < 0.05).  However, there were no 
differences in STARD1 mRNA expression in cows supplemented with fish meal 
that maintained a non-regressed or regressed corpus luteum at 0, 12, or 18 h (P 
> 0.05).   
 Changes in CYP11A1 luteal steady-state mRNA in response to saline and 
prostaglandin F2α are shown in Figure 7.  There was a main effect of treatment 
and time on steady-state mRNA expression on CYP11A1 (P < 0.05).  In animals 
that were supplemented with corn gluten meal and administered two doses of 
prostaglandin F2α, steady-state mRNA levels of CYP11A1 decreased at 6, 12, 
and 18 h time points when compared to saline treated animals (P < 0.05).  
Additionally, there was no difference in CYP11A1 mRNA expression between 
fish meal or corn gluten meal supplemented animals treated with prostaglandin 
F2α (P > 0.05).  In fish meal supplemented animals there was no change in 
CYP11A1 steady-state mRNA following administration of prostaglandin F2α in 
animals that maintained a non-regressed corpus luteum or animals that had a 
regressed gland. (P > 0.05).  In fish meal supplemented animals that had a 
regressed corpus luteum, CYP11A1 steady-state mRNA levels were decreased 
at both 6 and 18 h time points (P < 0.05).  However, CYP11A1 mRNA expression 
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decreased at the 12 h time point in fish meal supplemented animals that 
maintained a non-regressed corpus luteum (P < 0.05).  
 Changes in luteal steady-state mRNA expression of 3βHSD throughout 
the experimental period are shown in Figure 8. There was a main effect of 
treatment and time on steady-state mRNA expression for 3βHSD (P < 0.05).  
Steady-state mRNA of 3βHSD decreased in corn gluten meal supplemented 
animals that were treated with two doses of prostaglandin F2α compared to 
saline treated animals and continued to decline throughout the experimental 
period (P < 0.05).  At 0 h time point there was no difference in 3βHSD steady-
state mRNA levels in fish meal supplemented animals that received two infusions 
of prostaglandin F2α, regardless of luteal function (P > 0.05).  In fish meal 
supplemented animals that received two doses of prostaglandin F2α there was a 
decrease in 3βHSD steady-state mRNA levels at the 6 h time point for cows with 
a regressed corpus luteum (P < 0.05).  The steady-state mRNA levels of 3βHSD 
in cows with a regressed corpus luteum continued to decrease throughout the 
experimental period (P < 0.05).  However, in fish meal supplemented animals 
that received two doses of prostaglandin F2α and maintained a non-regressed 
corpus luteum, the steady-state mRNA levels of 3βHSD did not decrease 
following treatment with prostaglandin F2α (P > 0.05).   
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Figure 5: Effects corn gluten meal or fish meal supplementation on steady 
state mRNA of LDLR following low dose administration of prostaglandin 
F2α.  Effects of corn gluten meal or fish meal on steady-state gene expression of 
enzymes involved in progesterone biosynthesis following intrauterine infusions of 
prostaglandin F2α . Cows were administered four intrauterine infusions of 0.25 
mL saline or two intrauterine infusions of 0.5 mg prostaglandin F2α between day 
10 and 12 following a synchronized estrus. Cows were administered 
prostaglandin F2α at the first (0 h) and third (12 h) infusion and saline at the 
second (6 h) and fourth infusion (18 h). Steady-state mRNA expression of LDLR.  
Animals supplemented with corn gluten meal (open bar; n = 6) or fish meal 
(closed bar; n = 5) and infused with four doses of saline. Animals supplemented 
with corn gluten meal (open bar; n = 6) or fish meal (closed bar; n = 5) and 
infused with four doses of saline. Animals supplemented with corn gluten meal 
(regressed; dotted bar; n = 10) or fish meal (regressed; diagonal bar; n = 5; non-
regressed gray bar; n = 6) following intrauterine infusions of prostaglandin F2α . 
Within time, means with different lettersabc differ significantly within treatment (P < 
0.05) 
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Figure 6: Effects of corn gluten meal or fish meal supplementation on 
steady state mRNA of STARD1 expression following low dose intrauterine 
infusion of prostaglandin F2α.  Effects of corn gluten meal or fish meal on 
steady-state gene expression of enzymes involved in progesterone biosynthesis 
following intrauterine infusions of prostaglandin F2α. Cows were administered 
four intrauterine infusions of 0.25 mL saline or two intrauterine infusions of 0.5 
mg prostaglandin F2α between day 10 and 12 following a synchronized estrus. 
Cows were administered prostaglandin F2α at the first (0 h), third (12 h) infusion, 
saline at the second (6 h), and fourth infusion (18 h). Steady-state mRNA 
expression of luteal STARD1.  Animals supplemented with corn gluten meal 
(open bar; n = 6) or fish meal (closed bar; n = 5) and infused with four doses of 
saline. Animals supplemented with corn gluten meal (regressed; dotted bar; n = 
10) or fish meal (regressed; diagonal bar; n = 5; non-regressed gray bar; n = 6) 
following intrauterine infusions of prostaglandin F2α . Within time, means with 
different lettersabc differ significantly within treatment (P < 0.05) 
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Figure 7: Effects of corn gluten meal or fish meal supplementation on 
steady-state mRNA levels of CYP11A1 in response to low dose intrauterine 
infusions of prostaglandin F2α.  Effects of corn gluten meal or fish meal on 
steady-state gene expression of enzymes involved in progesterone biosynthesis 
following intrauterine infusions of prostaglandin F2α. Cows were administered 
four intrauterine infusions of 0.25 mL saline or two intrauterine infusions of 0.5 
mg prostaglandin F2α between day 10 and 12 following a synchronized estrus. 
Cows were administered prostaglandin F2α at the first (0 h) and third (12 h) 
infusion and saline at the second (6 h) and fourth infusion (18 h). Steady-state 
mRNA expression of luteal CYP11A1.  Animals supplemented with corn gluten 
meal (open bar; n = 6) or fish meal (closed bar; n = 5) and infused with four 
doses of saline. Animals supplemented with corn gluten meal (regressed; dotted 
bar; n = 10) or fish meal (regressed; diagonal bar; n = 5; non-regressed gray bar; 
n = 6) following intrauterine infusions of prostaglandin F2α . Within time, means 
with different lettersabc differ significantly within treatment (P < 0.05) 
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Figure 8: Effects of corn gluten meal or fish meal supplementation on 
steady-state mRNA levels of 3βHSD following low dose intrauterine 
infusion of prostaglandin F2α.  Effects of corn gluten meal or fish meal on 
steady-state gene expression of enzymes involved in progesterone biosynthesis 
following intrauterine infusions of prostaglandin F2α. Cows were administered 
four intrauterine infusions of 0.25 mL saline or two intrauterine infusions of 0.5 
mg prostaglandin F2α between day 10 and 12 following a synchronized estrus. 
Cows were administered prostaglandin F2α at the first (0 h) and third (12 h) 
infusion and saline at the second (6 h) and fourth infusion (18 h). Steady-state 
mRNA expression of luteal 3βHSD.  Animals supplemented with corn gluten 
meal (open bar; n = 6) or fish meal (closed bar; n = 5) and infused with four 
doses of saline. Animals supplemented with corn gluten meal (open bar; n = 6) or 
fish meal (closed bar; n = 5) and infused with four doses of saline. Animals 
supplemented with corn gluten meal (regressed; dotted bar; n = 10) or fish meal 
(regressed; diagonal bar; n = 5; non-regressed gray bar; n = 6) following 
intrauterine infusions of prostaglandin F2α . Within time, means with different 
lettersabc differ significantly within treatment (P < 0.05). 
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Luteolytic Genes Steady-State 
Messenger Ribonucleic 
Acid Expression 
 Data regarding steady-state mRNA expression of the PTGFR and PGHS2 
enzyme are shown in Figure 9.  There was a main effect of treatment and time 
on steady-state mRNA expression of these genes (P < 0.05).  Biopsies of the 
corpus luteum were taken 30 min post intrauterine infusion of either saline or 
prostaglandin F2α to determine the effect of corn gluten meal or fish meal 
supplementation on steady-state mRNA levels of two luteolytic genes.  In saline 
treated animals, there were no differences in PTGFR steady-state mRNA level 
between supplementation groups (P > 0.05).  However, following administration 
of prostaglandin F2α, there was a decrease in PTGFR steady-state mRNA levels 
in corn gluten meal supplemented animals. (P < 0.05).  There were no 
differences in PTGFR expression in fish meal supplemented animals with a non-
regressed corpus luteum when compared to animals with a regressed gland (P > 
0.05).   
 Steady-state mRNA expression of PGHS2 did not differ between control 
animals treated with saline, regardless of fish meal or corn gluten meal 
supplementation (P > 0.05).  Additionally, there were no changes in PGHS2 
expression between saline treated animals and prostaglandin F2α treated 
animals (P > 0.05).  Levels of PGHS2 expression did not differ between animals 
with a regressed corpus luteum and animals that retained a non-regressed 
corpus luteum (P > 0.05).   
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Figure 9: Effects of corn gluten meal or fish meal supplementation on 
steady-state mRNA levels of luteolytic genes (PTGFR and PGHS2) 
following low dose intrauterine infusion of prostaglandin F2α.  Effects of 
corn gluten meal or fish meal on steady-state gene expression of enzymes 
involved in progesterone biosynthesis following intrauterine infusions of 
prostaglandin F2α. Cows were administered four intrauterine infusions of 0.25 
mL saline or two intrauterine infusions of 0.5 mg prostaglandin F2α between day 
10 and 12 following a synchronized estrus. Cows were administered 
prostaglandin F2α at the first (0 h) and third (12 h) infusion and saline at the 
second (6 h) and fourth infusion (18 h). Steady-state mRNA expression of luteal 
PTGFR and PGHS2.  Animals supplemented with corn gluten meal (open bar; n 
= 6) or fish meal (closed bar; n = 5) and infused with four doses of saline. 
Animals supplemented with corn gluten meal (regressed; dotted bar; n = 10) or 
fish meal (regressed; diagonal bar; n = 5; non-regressed gray bar; n = 6) 
following intrauterine infusions of prostaglandin F2α . Within time, means with 
different lettersabc differ significantly within treatment (P < 0.05) 
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Apoptotic Genes Steady-State 
Messenger Ribonucleic 
Acid Expression 
 Cows were supplemented for 60 days with either corn gluten meal or fish 
meal and luteal biopsies were taken every 6 h for an 18 h treatment period to 
determine steady-state mRNA expression for three target apoptotic genes of 
interest: BAX, BCL-2, and CAS3 (data shown in Figure 10).   
 In animals treated with saline, there were no differences in BAX steady-
state mRNA levels in animals supplemented with corn gluten meal or fish meal 
(P > 0.05).  There were no changes in BAX expression following administration of 
prostaglandin F2α in animals supplemented with fish meal (P > 0.05).  However, 
BAX steady-state mRNA was elevated at the 18 h time point in animals 
supplemented with corn gluten meal compared to those supplemented with fish 
meal following infusion of prostaglandin F2α (P < 0.05).   
 In animals treated with four doses of saline, steady-state mRNA 
expression of BCL-2 differed between supplementation groups. Levels of BCL-2 
steady-state mRNA expression was increased in fish meal supplemented 
animals (P < 0.05).  Animals administered prostaglandin F2α, regardless of 
supplementation group, had a decrease in BCL-2 expression (P < 0.05). There 
were no changes in BCL-2 expression in both subpopulations of fish meal 
supplemented animals following administration of prostaglandin F2α.  (P > 0.05).   
Steady-state mRNA expression of CAS3 did not differ between saline 
treated animals supplemented with either corn gluten meal or fish meal 
supplemented (P > 0.05).  Steady-state mRNA expression of CAS3 was elevated 
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at the 18 h time point in corn gluten meal supplemented animals treated with 
prostaglandin F2α (P < 0.05).  However, in fish meal supplemented animals 
treated with prostaglandin F2α, expression of CAS3 did not increase and did not 
differ from saline treated animals (P > 0.05).   
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Figure 10: Corn gluten meal or fish meal supplementation on apoptotic 
genes (BAX, BCL-2, CAS3) following intrauterine infusions of prostaglandin 
F2α.  Effects of corn gluten meal or fish meal on steady-state gene expression of 
enzymes involved in progesterone biosynthesis following intrauterine infusions of 
prostaglandin F2α . Cows were administered four intrauterine infusions of 0.25 
mL saline or two intrauterine infusions of 0.5 mg prostaglandin F2α between day 
10 and 12 following a synchronized estrus. Cows were administered 
prostaglandin F2α at the first (0 h) and third (12 h) infusion and saline at the 
second (6 h) and fourth infusion (18 h). Steady-state mRNA expression of luteal 
BAX, BCL-2 and CAS3.  Animals supplemented with corn gluten meal (open bar; 
n = 6) or fish meal (closed bar; n = 5) and infused with four doses of saline. 
Animals supplemented with corn gluten meal (regressed; dotted bar; n = 10) or 
fish meal (regressed; diagonal bar; n = 5; non-regressed gray bar; n = 6) 
following intrauterine infusions of prostaglandin F2α . Within time, means with 
different lettersabc differ significantly within treatment (P < 0.05). 
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CHAPTER IV 
DISCUSSION 
 Nutrition and specifically energy availability can effect reproduction in the 
bovine (129, 130).  A reduction in energy intake has been reported to decrease 
luteinizing hormone secretion, diameter of the corpus luteum and progesterone 
biosynthesis (131).  Often, fat is added to the diet of breeding cows to 
compensate for lowered energy levels.  Clearly, inclusion of fat in the diet 
overcame energy deficits and improved reproductive performance (132).  
Additionally, omega-3 fatty acids found in some sources of dietary fats, such as 
fish products, may have a direct effect on reproduction. 
Reports in the literature have shown that omega-3 fatty acids in fish meal 
and oil escape ruminal hydrogenation (133) and are incorporated into the blood, 
making it available for incorporation into reproductive tissues (134).  Indeed, 
recent reports in the literature show that omega-3 fatty acids from fish products 
influence endometrial oxytocin-induced prostaglandin F2α secretion (135, 136) 
and luteal function in response to uterine infusion of prostaglandin F2α in the 
bovine (137).   
Regarding luteal function, it was shown that uterine infusion of 
prostaglandin F2α caused regression (serum progesterone <1 ng/mL within 48h) 
in approximately 90% of the cows supplemented with corn gluten meal but only 
in 50% of cows receiving fish meal.  This study sought to elucidate the effects of 
49 
 
 
 
fish meal supplementation on luteal gene expression in response to low-doses of 
prostaglandin F2α administration in cows that have a regressed or non-regressed 
corpora lutea.  
There were no changes in expression of target genes throughout the 
experimental period in response to saline administration for cows supplemented 
with corn gluten meal.  This agrees with previous studies showing that repeated 
luteal biopsies did not affect gene expression (137).  Therefore, any changes in 
gene expression were due to prostaglandin F2α treatment or dietary 
supplementation and not due to reproductive tract manipulation or inflammatory 
responses from repeated luteal biopsies.  In addition, there was no influence of 
dietary supplementation of fish meal on global expression of genes of interest.  
Regardless of luteal function, there was a reduction in LDLR, STARD1 
and CYP11A1 steady-state mRNA levels in all fish meal supplemented animals 
treated with prostaglandin F2α.  Interestingly, steady-state mRNA levels for  
3βHSD remained unchanged in fish meal supplemented animals that were 
infused with prostaglandin F2α and maintained a non-regressed corpus luteum.  
However, animals with a regressed corpus luteum had a significant decrease in 
3βHSD expression.  This could indicate that 3βHSD expression or upstream 
regulatory pathways may play a critical role in altering luteal function and 
progesterone output in response to prostaglandin F2α.   
Previous studies in the literature show a decrease in luteotropic gene 
expression in response to prostaglandin F2α (59, 137).  Dietary fish meal 
supplementation may be adequate to maintain luteotropic gene expression, 
50 
 
 
 
particularly of 3βHSD, and prevent critical loss of progesterone output, thus 
retaining a non-regressed corpus luteum following prostaglandin F2α 
administration.  The maintenance of 3βHSD steady-state mRNA could be 
adequate to prevent functional regression of the corpus luteum following 
exposure to prostaglandin F2α.  Additionally, despite the decrease in LDLR, 
STARD1, and CYP11A1 mRNA levels, this may not be indicative of protein 
abundance or activity in luteal tissue and requires further investigation.  Also, it is 
possible a rebound in steady state mRNA for LDLR, STARD1, and CYP11A1 
may occur between 18 and 48 h of the experimental period in animals that 
retained a non-regressed corpus luteum following administration of prostaglandin 
F2α.  
Secretion of uterine prostaglandin F2α late in the estrous cycle initiates an 
intracellular signaling cascade that leads to the functional and structural 
regression of the corpus luteum.  It has been postulated that luteal prostaglandin 
F2α synthesis is required for complete luteolysis (138).  Reports in the literature 
show that administration of intrauterine prostaglandin F2α leads to a 5-10 fold 
increase in PGHS2 mRNA expression, supporting the hypothesis that luteal 
production of prostaglandin F2α may be needed for regression of the corpus 
luteum.  In contrast to recent reports in the literature, there was no increase in 
luteal PGHS2 mRNA expression following administration of prostaglandin F2α in 
the current study.  Additionally, there was no difference in luteal PGHS2 
expression between corn gluten meal and fish meal supplemented animals.  
Discrepancies between the current study wherein there was no change in mRNA 
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expression of PGHS2 compared to reports in the literature where prostaglandin 
F2α increased expression of PGHS2 could be due to physiological status of 
animals studied.  Non-lactating beef cows were used in the current study as 
opposed to the use of Holstein heifers used in previous studies reported in the 
literature (139).  Doses of prostaglandin F2α, timing and delivery routes were 
similar between studies.  However, it is possible that body weight (cow vs heifer) 
or maturity (growing heifer vs mature cow) could influence transfer of 
prostaglandin F2α from the uterus to the luteal vasculature and or clearance of 
prostaglandin F2α.  Additional studies are required to determine the influence of 
fish products on luteal prostaglandin metabolism and vascular transfer.     
There were no differences in steady-state mRNA levels of PTGFR 
between animals supplemented with corn gluten meal or fish meal that were 
administered intrauterine infusions of saline.  Steady-state mRNA of PTGFR 
decreased in response to prostaglandin F2α treatment, regardless of dietary 
supplementation or luteal function.  Previous reports in the literature show a 
decrease in PTGFR expression following treatment with prostaglandin F2α (139).  
In contrast to recent reports in the literature, there was no difference in PTGFR 
expression in prostaglandin F2α treated animals that had a regressed corpus 
luteum compared to those that retained a non-regressed gland.  It is possible that 
no change in PTGFR mRNA was due to biopsy collection time post-intrauterine 
infusion and resulted in a lack of detectible differences in steady-state mRNA 
levels.   
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The effects of fish meal supplementation on the apoptotic gene expression 
of BAX, BCL-2, and CAS3 steady-state mRNA levels were examined.  
Interestingly, BCL-2 steady-state mRNA levels in fish meal supplemented 
animals treated with saline was elevated compared to saline treated corn gluten 
supplemented animals and animals treated with prostaglandin F2α.  Typically, 
BCL-2 expression remains the same during luteolysis, while an increase in the 
ratio of BAX to BCL-2 expression can be used as a biomarker to identify 
apoptotic cells (140).  In the present study, there were no differences in BAX or 
BCL-2 mRNA levels, regardless of dietary supplementation group, following 
exposure to prostaglandin F2α.  The experimental period of 18 hours may not be 
long enough to detect significant increase in BAX mRNA expression.  An 
extended biopsy collection may be necessary to determine when BAX 
expression may become elevated within the corpus luteum.  Additionally, both 
BAX and BCL-2 proteins are associated with the intrinsic pathway of apoptosis.  
It is possible that lack in observable change in BAX and BCL-2 expression 
following administration of prostaglandin F2α could be due to apoptosis being 
signaled through an extrinsic pathway of apoptosis instead.  Extrinsic apoptosis 
could be initiated by FAS/FASL, TNFα, or TRAIL signaling, leading to 
downstream activation of effector caspases, resulting in apoptosis (141).  
Apoptotic signaling via an extrinsic pathway could explain a lack in change of 
BAX and BCL-2 and warrants further investigation.  
 Surprisingly, there was no change in CAS3 expression in either corn 
gluten meal or fish meal supplemented animals following administration of 
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prostaglandin F2α.  Previous studies in the literature show an increase in CAS3 
mRNA expression following exposure to PGF2α (142, 143).  The activation of 
CAS3 will lead to activation of caspase activated DNases, leading to DNA 
fragmentation and apoptosis.  CAS3 is an effector caspase that is activated 
downstream of both intrinsic and extrinsic apoptotic pathways and it was 
expected that CAS3 expression would increase in luteal tissue following 
exposure to prostaglandin F2α regardless of apoptotic signaling pathway.  
However, dosage of prostaglandin F2α and its effects on gene expression must 
be taken into consideration.  A physiological dose of prostaglandin F2α (0.5mg) 
was administered in the current study; whereas reports in the literature that 
showed an increase in CAS3 expression administered pharmacological doses 
(20mg or greater) of prostaglandin F2α (144).  Differences in doses of 
prostaglandin F2α could explain the lack of change in CAS3 steady-state mRNA 
levels.  Additionally, an alternative signaling pathway leading to apoptosis may 
explain why CAS3 steady-state mRNA levels remained unchanged.  A novel 
apoptotic pathway was recently reported in the literature describing an 
endoplasmic reticulum stress-mediated pathway for apoptosis.  Endoplasmic 
stress was shown to activate caspase 12 protein (145) and downstream 
activation of CAS3 expression.  It is possible that a CAS3 activation by caspase 
12 occurs after 48 h of initial prostaglandin F2α administration, resulting in non-
detectable changes in CAS3 steady-state mRNA in the present study.  An 
extended biopsy period may be necessary to detect an increase in CAS3 
expression.   
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The effects of dietary fish meal supplementation on the expression of FOS 
and NR4A1 were examined.  These two genes are classified as immediate early 
genes and have been shown to play a role in luteal function and expression of 
luteotropic genes (83, 146).  A previous study conducted in the cow showed that 
both FOS and NR4A1 expression increases following administration of 
prostaglandin F2α (147). 
In the present study, there was no change in either FOS or NR4A1 
expression following saline administration between cows supplemented with 
either corn gluten meal or fish meal.  This indicates that fish meal 
supplementation did not influence expression of these immediate early genes.  
However, cows receiving two doses of prostaglandin F2α had a significant 
increase in FOS and NR4A1 expression within 30 min following treatment, which 
agrees with a previous study using a similar animal model (139).  More 
experiments are necessary to determine differences in gene expression between 
FOS and NR4A1 and downstream signaling following administration of 
prostaglandin F2α. 
 
 
 
 
 
 
55 
 
 
 
 
 
 
 
CHAPTER V 
CONCLUSION 
Previous studies in our laboratory show the successful incorporation of 
omega-3 fatty acids found in fish oils into bovine luteal tissue.  Supplementation 
with omega-3 fatty acids affects prostaglandin F2α signaling and luteal 
sensitivity.  Additionally, reports in the literature show that fish oil 
supplementation of bovine luteal cells altered internalization of the PTGFR and 
endosomal trafficking of PTGFR protein (148).  Fish oil supplementation has 
been shown to cause a disruption in lipid microdomains and lateral mobility of the 
PTGFR, thereby affecting prostaglandin F2α induced signaling and luteal 
sensitivity (149).  Increase in PTGFR mobility will result in a lower likelihood of 
prostaglandin F2α binding to its receptor and initiating intracellular signaling 
cascades that cause luteal regression.  Therefore, it was expected that fish meal 
supplementation affects luteal gene expression and signaling following 
administration of prostaglandin F2α.   
Responsiveness to prostaglandin F2α was expected to be reduced in fish 
meal supplemented animals that retained a non-regressed corpus luteum.  
Surprisingly, the incorporation of omega-3 fatty acids into luteal tissue did not 
seem to affect immediate early or luteolytic gene expression when compared to 
animals supplemented with corn gluten meal.  Despite changes in PTGFR 
signaling in previous reports in the literature, the lack in change of immediate 
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early or luteolytic gene expression indicates an alternative pathway ultimately 
leading to regression of the corpus luteum.  Additionally, expression of 3βHSD 
may be an important biomarker in regressed or non-regressed corpora lutea 
following administration of prostaglandin F2α.  More research must be completed 
to investigate differences in animals that retained a non-regressed corpus luteum 
following administration of prostaglandin F2α compared to animals that had a 
regressed corpus luteum.    
  
 
 
 
 
 
 
 
 
 
 
 
 
57 
 
 
 
REFERENCES 
1. Prenant, A. (1898) The morphological value of the corpus luteum. Its 
physiological and therapeutic actions are possible. Reviews in General 
Science Pure Applications 9, 646–650. 
2. Frobenius, W. (1998). Ludwig Fraenkel, corpus luteum and discovery 
of progesterone. Zentralbl Gynakol 120, 317–323  
3. Allen, A., and Heckel, G. (1938). Maintenance of pregnancy by 
progesterone in rabbits castrated on the 11th day. American Journal of 
Physiology-Legacy Content. 
4. Pincus, G., and Werthessen, N.T. (1938). The maintenance of embryo 
life in ovariectomized rabbits. American Journal of Physiology-Legacy 
Content. 
5. Willard Allen. (1970). Crystalline Progesterone. Science. 80, 190-191 
6. Allen, W. and Goetsh, C. (1936).  A simplified method for the 
preparation of crystalline progesterone* from pig ovaries.  Journal of 
Biological Chemistry 116, 653-652  
7. Corner, G.W. (1937). The Hormone of the Corpus Luteum.  15th 
December 1936. Transactions of Edinburgh Obstetrical Society 57, 
61–80. 
8. Graham, J.D., and Clarke, C.L. (1997). Physiological Action of 
Progesterone in Target Tissues. Endocrinology Reviews 18, 502-19.  
9. Armstrong, D.T. and Black, D.L. (1966) Influence of Luteinizing 
Hormone on Corpus Luteum Metabolism and Progesterone 
58 
 
 
 
Biosynthesis Throughout the Bovine Estrous Cycle. Endocrinology 78, 
937. 
10. Girmus, R.L., and Wise, M.E. (1991). Direct pituitary effects of estradiol 
and progesterone on luteinizing hormone release, stores, and subunit 
messenger ribonucleic acids. Biology of Reproduction 45, 128–134. 
11. Batra, S., Bengtsson, L.P., Grundsell, H., and Sjöberg, N.O. (1976).  
Levels of Free and Protein-Bound Progesterone in Plasma During Late  
Pregnancy. The Journal of Clinical Endocrinology & Metabolism 42,  
1041–1047. 
12. Hammond, G.L. (2016). Plasma steroid-binding proteins: primary 
gatekeepers of steroid hormone action. Journal of Endocrinology 230, 
R13–R25. 
13. Kaya, S., Kaçar, C., Polat, B., Çolak, A., Kaya, D., Gürcan, İ.S., 
Bollwein, H., and Aslan, S. (2017). Association of luteal blood flow with 
follicular size, serum estrogen and progesterone concentrations, and 
the inducibility of luteolysis by PGF 2α in dairy cows. Theriogenology 
87, 167–172. 
14. Diskin, M.G., Parr, M.H., and Morris, D.G. (2011).  Embryo death in  
cattle: an update.  Reproduction Fertility and Development. 24, 244– 
251.  
15. Berg, D.K., van Leeuwen, J., Beaumont, S., Berg, M., and Pfeffer, P.L. 
(2010). Embryo loss in cattle between Days 7 and 16 of pregnancy. 
Theriogenology 73, 250–260. 
59 
 
 
 
16. Diskin, M.G., Waters, S.M., Parr, M.H., Kenny, D.A. (2016). Pregnancy  
losses in cattle: potential for improvement.  Reproduction, Fertility and  
Development 28, 83-93 
17. Sakumoto, R., Hayashi, K.-G., and Takahashi, T. (2014). Different 
expression of PGE synthase, PGF receptor, TNF, Fas and oxytocin in 
the bovine corpus luteum of the estrous cycle and pregnancy. 
Reproductive Biology 14, 115–121. 
18. Mann, G.E., Lamming, G.E., Robinson, R.S., and Wathes, D.C. (1999). 
The regulation of interferon-tau production and uterine hormone 
receptors during early pregnancy. Journal of Reproduction and Fertility 
Suppl 54, 317–328. 
19. Roberts, R.M. (2009). Interferon-τ and Pregnancy. Journal of Interferon  
Cytokine Research 16, 271-273. 
20. Meyer, M.D., Desnoyers, G.D., Oldick, B., and Drost, M. (1996).  
Treatment with Recombinant Bovine Interferon-Tau In Utero 
Attenuates Secretion of Prostaglandin F from Cultured Endometrial  
Epithelial Cells. Journal of Dairy Science 79, 1375-84 
21. Senger PL (1997) Pathways to pregnancy and parturition (Current 
Conceptions, Inc., 1615 NE Eastgate Blvd.). 
22. Fields, M.J., and Fields, P.A. (1996). Morphological characteristics of 
the bovine corpus luteum during the estrous cycle and pregnancy. 
Theriogenology 45, 1295–1325. 
60 
 
 
 
23. Yoshioka, S., Abe, H., Sakumoto, R., and Okuda, K. (2013). 
Proliferation of Luteal Steroidogenic Cells in Cattle. PLOS ONE 8, 
e84186. 
24. Davis, J.S., Rueda, B.R., and Spanel-Borowski, K. (2003). 
Microvascular endothelial cells of the corpus luteum. Reproduction 
Biology and Endocrinology 1, 89. 
25. Murphy, B.D. (2000). Models of Luteinization. Biology of Reproduction.   
63, 2-11. 
26. Fadhillah, Yoshioka, S., Nishimura, R., and Okuda, K. (2014). Hypoxia 
Promotes Progesterone Synthesis During Luteinization in Bovine 
Granulosa Cells. Journal of Reproduction and Development 60, 194–
201. 
27. Arosh, J.A., Banu, S.K., Chapdelaine, P., Madore, E., Sirois, J., and 
Fortier, M.A. (2004). Prostaglandin Biosynthesis, Transport, and 
Signaling in Corpus Luteum: A Basis for Autoregulation of Luteal 
Function. Endocrinology 145, 2551–2560. 
28. Stocco, C., Telleria, C., and Gibori, G. (2007). The Molecular Control of 
Corpus Luteum Formation, Function, and Regression. Endocrine 
Reviews 28, 117–149. 
29. Nishimura, R., and Okuda, K. (2010). Hypoxia is Important for 
Establishing Vascularization During Corpus Luteum Formation in 
Cattle. Journal of Reproduction and Development 56, 110–116. 
61 
 
 
 
30. Fadhillah, Yoshioka, S., Nishimura, R., Yamamoto, Y., Kimura, K., and 
Okuda, K. (2017). Hypoxia-inducible factor 1 mediates hypoxia-
enhanced synthesis of progesterone during luteinization of granulosa 
cells. Journal of Reproduction and Development 63, 75–85. 
31. Kowalewski, M.P., Gram, A., and Boos, A. (2015). The role of hypoxia 
and HIF1α in the regulation of STAR-mediated steroidogenesis in 
granulosa cells. Molecular and Cellular Endocrinology 401, 35–44. 
32. Jiang, Y.-F., Tsui, K.-H., Wang, P.-H., Lin, C.-W., Wang, J.-Y., Hsu, 
M.-C., Chen, Y.-C., and Chiu, C.-H. (2011). Hypoxia regulates cell 
proliferation and steroidogenesis through protein kinase A signaling in 
bovine corpus luteum. Animal Reproduction Science 129, 152–161. 
33. Gabler, C., Plath-Gabler, A., Killian, G., Berisha, B., and Schams, D. 
(2004). Expression Pattern of Fibroblast Growth Factor (FGF) and 
Vascular Endothelial Growth Factor (VEGF) System Members in 
Bovine Corpus Luteum Endothelial Cells During Treatment with FGF-2, 
VEGF or Oestradiol: FGF and VEGF mRNA in Luteal Endothelial 
Cells. Reproduction in Domestic Animals 39, 321–327. 
34. Robinson, R.S., Nicklin, L.T., Hammond, A.J., Schams, D., Hunter, 
M.G., and Mann, G.E. (2007). Fibroblast Growth Factor 2 Is More 
Dynamic than Vascular Endothelial Growth Factor A During the 
Follicle-Luteal Transition in the Cow1. Biology of Reproduction 77, 28–
36. 
62 
 
 
 
35. Skarzynski, D.J., Piotrowska‐Tomala, K.K., Lukasik, K., Galvão, A., 
Farberov, S., Zalman, Y., and Meidan, R. (2013). Growth and 
Regression in Bovine Corpora Lutea: Regulation by Local Survival and 
Death Pathways. Reproduction in Domestic Animals 48, 25–37. 
36. Kfir, S., Basavaraja, R., Wigoda, N., Ben-Dor, S., Orr, I., and Meidan, 
R. (2018). Genomic profiling of bovine corpus luteum maturation. 
PLOS ONE 13, e0194456. 
37. Zheng, J., Redmer, D.A., and Reynolds, L.P. (1993). Vascular 
development and heparin-binding growth factors in the bovine corpus 
luteum at several stages of the estrous cycle. Biology of Reproduction 
49, 1177–1189. 
38. Perks, C.M., Peters, A.R., and Wathes, D.C. (1999). Follicular and 
luteal expression of insulin-like growth factors I and II and the type 1 
IGF receptor in the bovine ovary. Journal of Reproduction and Fertility 
116, 157–165. 
39. Moss, S., Wrenn, T.R., and Sykes, J.F. (1954). Some histological and 
histochemical observations of the bovine ovary during the estrous 
cycle. The Anatomical Record 120, 409–433. 
40. Niswender, G.D. (1981). Response of the corpus luteum to luteinizing 
hormone. Environmental Health Perspectives 38, 47–50. 
41. Stocco, C.O., Lau, L.F., and Gibori, G. (2002). A Calcium/Calmodulin-
dependent Activation of ERK1/2 Mediates JunD Phosphorylation and 
63 
 
 
 
Induction of nur77 and 20α-hsd Genes by Prostaglandin F 2α in 
Ovarian Cells. Journal of Biological Chemistry 277, 3293–3302. 
42. Chen, D. (2001). Induction of c-fos and c-jun Messenger Ribonucleic 
Acid Expression by Prostaglandin F2 Is Mediated by a Protein Kinase 
C-Dependent Extracellular Signal-Regulated Kinase Mitogen-Activated 
Protein Kinase Pathway in Bovine Luteal Cells. Endocrinology 142, 
887–895. 
43. Hu J, Zhang Z, Shen W-J, Azhar S. (2010) Cellular cholesterol 
delivery, intracellular processing and utilization for biosynthesis of 
steroid hormones. Nutrition Metabolism (Lond) 7, 47. 
44. Channing, C.P., and Tsafriri, A. (1977). Mechanism of action of 
luteinizing hormone and follicle-stimulating hormone on the ovary in 
vitro. Metabolism 26, 413–468. 
45. Okuda, K., Korzekwa, A., Shibaya, M., Murakami, S., Nishimura, R., 
Tsubouchi, M., Woclawek-Potocka, I., and Skarzynski, D.J. (2004). 
Progesterone Is a Suppressor of Apoptosis in Bovine Luteal Cells. 
Biology of Reproduction 71, 2065–2071. 
46. Rueda, B.R., Hendry, I.R., Hendry III, W.J., Stormshak, F., Slayden, 
O.D., and Davis, J.S. (2000). Decreased progesterone levels and 
progesterone receptor antagonists promote apoptotic cell death in 
bovine luteal cells. Biology of Reproduction 62, 269–276. 
47. Skinner, D.C., Evans, N.P., Delaleu, B., Goodman, R.L., Bouchard, P., 
and Caraty, A. (1998). The negative feedback actions of progesterone 
64 
 
 
 
on gonadotropin releasing hormone secretion are transduced by the 
classical progesterone receptor. Proceedings of National Academy of 
Science U S A 95, 10978–10983. 
48. Niswender, G.D., Juengel, J.L., McGuire, W.J., Belfiore, C.J., and 
Wiltbank, M.C. (1994). Luteal Function: The Estrous Cycle and Early 
Pregnancy. Biology of Reproduction 50, 239–247. 
49. Niswender, G.D., Juengel, J.L., Silva, P.J., Rollyson, M.K., and 
McIntush, E.W. (2000). Mechanisms Controlling the Function and Life 
Span of the Corpus Luteum. Physiological Reviews 80, 1–29. 
50. Beindorff, N., Nagai, K., Shirasuna, K., Herzog, K., Hoeffmann, K., 
Sasaki, M., Bollwein, H., and Miyamoto, A. (2010). Vascular changes 
in the corpus luteum during early pregnancy in the cow. Journal of 
Reproduction and Development 56, 263–270. 
51. Berisha, B., Schams, D., Kosmann, M., Amselgruber, W., and 
Einspanier, R. (2000). Expression and tissue concentration of vascular 
endothelial growth factor, its receptors, and localization in the bovine 
corpus luteum during estrous cycle and pregnancy. Biology of 
Reproduction 63, 1106–1114. 
52. Bowen-Shauver, J.M., and Telleria, C.M. (2003). Luteal regression: a 
redefinition of the terms. Reproduction Biology and Endocrinology 1, 
28. 
53. Silvia, W.J., Lewis, G.S., McCracken, J.A., Thatcher, W.W., and 
Wilson, L. (1991). Hormonal regulation of uterine secretion of 
65 
 
 
 
prostaglandin F2 alpha during luteolysis in ruminants. Biology of 
Reproduction 45, 655–663. 
54. Wiltbank, M.C., Shiao, T.F., Bergfelt, D.R., and Ginther, O.J. (1995). 
Prostaglandin F2 alpha receptors in the early bovine corpus luteum. 
Biology of Reproduction 52, 74–78. 
55. Wiltbank, M.C., Knickerbocker, J.J., and Niswender, G.D. (1989). 
Regulation of the corpus luteum by protein kinase C. I. 
Phosphorylation activity and steroidogenic action in large and small 
ovine luteal cells. Biology of Reproduction 40, 1194–1200. 
56. Wiltbank, M.C., Belfiore, C.J., and Niswender, G.D. (1993). 
Steroidogenic enzyme activity after acute activation of protein kinase 
(PK) A and PKC in ovine small and large luteal cells. Molecular Cell 
Endocrinology 97, 1–7. 
57. Kliem, H., Welter, H., Kraetzl, W.D., Steffl, M., Meyer, H.H.D., Schams, 
D., and Berisha, B. (2007). Expression and localisation of extracellular 
matrix degrading proteases and their inhibitors during the oestrous 
cycle and after induced luteolysis in the bovine corpus luteum. 
Reproduction 134, 535–547. 
58. Ginther, O.J., and Beg, M.A. (2012). Dynamics of Circulating 
Progesterone Concentrations Before and During Luteolysis: A 
Comparison Between Cattle and Horses. Biology of Reproduction 86. 
66 
 
 
 
59. Pescador, N., Soumano, K., Stocco, D.M., Price, C.A., and Murphy, 
B.D. (1996). Steroidogenic Acute Regulatory Protein in Bovine Corpora 
Lutea. Biology of Reproduction 55, 485–491. 
60. Rodgers, R.J., Vella, C.A., Young, F.M., Tian, X.C., and Fortune, J.E. 
(1995). Concentrations of cytochrome P450 cholesterol side-chain 
cleavage enzyme and 3 beta-hydroxysteroid dehydrogenase during 
prostaglandin F2 alpha-induced luteal regression in cattle. 
Reproduction Fertility and Development 7, 1213–1216. 
61. Seto, N.L., and Bogan, R.L. (2015). Decreased Cholesterol Uptake 
and Increased Liver X Receptor-Mediated Cholesterol Efflux Pathways 
During Prostaglandin F2 Alpha-Induced and Spontaneous Luteolysis in 
Sheep. Biology of Reproduction 92. 
62. Wang, Z., Tamura, K., Yoshie, M., Tamura, H., Imakawa, K., and 
Kogo, H. (2003). Prostaglandin F2α-Induced Functional Regression of 
the Corpus Luteum and Apoptosis in Rodents. Journal of 
Pharmacological Sciences 92, 19–27. 
63. Horihata, K., Yoshioka, S., Sano, M., Yamamoto, Y., Kimura, K., 
Skarzynski, D.J., and Okuda, K. (2017). Expressions of lipoprotein 
receptors and cholesterol efflux regulatory proteins during luteolysis in 
bovine corpus luteum. Reproduction Fertility and Development 29, 
1280–1286. 
64. Mamluk, R., Greber, Y., and Meidan, R. (1999). Hormonal Regulation 
of Messenger Ribonucleic Acid Expression for Steroidogenic Factor-1, 
67 
 
 
 
Steroidogenic Acute Regulatory Protein, and Cytochrome P450 Side-
Chain Cleavage in Bovine Luteal Cells. Biology of Reproduction 60, 
628–634. 
65. Manna, P.R., Dyson, M.T., and Stocco, D.M. (2009). Regulation of the 
steroidogenic acute regulatory protein gene expression: present and 
future perspectives. Molecular Human Reproduction 15, 321–333. 
66. Joy L Pate, and P Landis Keyes (2001). Immune cells in the corpus 
luteum: friends or foes? Reproduction 122, 665–676. 
67. Kfir, S., Basavaraja, R., Wigoda, N., Ben-Dor, S., Orr, I., and Meidan, 
R. (2018). Genomic profiling of bovine corpus luteum maturation. 
PLOS ONE 13, e0194456. 
68. Penny, L.A., Armstrong, D., Bramley, T.A., and Webb, R. (1999). 
Immune cells and cytokine production in the bovine corpus luteum 
throughout the oestrous cycle and after induced luteolysis. Journal of 
Reproduction and Fertility 115, 87–96. 
69. Taniguchi, H., Yokomizo, Y., and Okuda, K. (2002). Fas-Fas Ligand 
System Mediates Luteal Cell Death in Bovine Corpus Luteum. Biology 
of Reproduction 66, 754–759. 
70. Cavicchio, V.A., Pru, J.K., Davis, B.S., Davis, J.S., Rueda, B.R., and 
Townson, D.H. (2002). Secretion of Monocyte Chemoattractant 
Protein-1 by Endothelial Cells of the Bovine Corpus Luteum: 
Regulation by Cytokines But Not Prostaglandin F2α. Endocrinology 
143, 3582–3589. 
68 
 
 
 
71. Pru, J.K., Lynch, M.P., Davis, J.S., and Rueda, B.R. (2003). Signaling 
mechanisms in tumor necrosis factor alpha-induced death of 
microvascular endothelial cells of the corpus luteum. Reproductive 
Biology and Endocrinology 11. 
72. Suter, J., Hendry, I.R., Ndjountche, L., Obholz, K., Pru, J.K., Davis, 
J.S., and Rueda, B.R. (2001). Mediators of Interferon γ-Initiated 
Signaling in Bovine Luteal Cells. Biology of Reproduction 64, 1481–
1486. 
73. Luo, W., Urano, F., and Wiltbank, M.C. (2009). Stage-Specific 
Responses in Gene Expression and Signaling Pathway Activation after 
Treatment with Prostaglandin F2 Alpha (PGF) and Interferon-Gamma 
(IFNG) in Bovine Corpus Luteum (CL) and Luteinizing Granulosa Cells. 
Biology of Reproduction 81, 53–53. 
74. Kliem, H., Berisha, B., Meyer, H.H.D., and Schams, D. (2009). 
Regulatory changes of apoptotic factors in the bovine corpus luteum 
after induced luteolysis. Molecular Reproduction and Development 76, 
220–230. 
75. Rueda, B.R., Tilly, K.I., Botros, I.W., Jolly, P.D., Hansen, T.R., Hoyer, 
P.B., and Tilly, J.L. (1997). Increased bax and Interleukin-1β-
Converting Enzyme Messenger Ribonucleic Acid Levels Coincide with 
Apoptosis in the Bovine Corpus Luteum during Structural Regression. 
Biology of Reproduction 56, 186–193. 
69 
 
 
 
76. Ford, S.P., and Chenault, J.R. (1981). Blood flow to the corpus luteum-
bearing ovary and ipsilateral uterine horn of cows during the oestrous 
cycle and early pregnancy. Journal of Reproduction and Fertility 62, 
555–562. 
77. Neuvians, T.P., Berisha, B., and Schams, D. (2004). Vascular 
endothelial growth factor (VEGF) and fibroblast growth factor (FGF) 
expression during induced luteolysis in the bovine corpus luteum. 
Molecular Reproduction and Development 67, 389–395. 
78. Tetsuka, M., Yamamoto, S., Hayashida, N., Hayashi, K.G., Hayashi, 
M., Acosta, T.J., and Miyamoto, A. (2003). Expression of 11beta-
hydroxysteroid dehydrogenases in bovine follicle and corpus luteum. 
Journal of Endocrinology 177, 445–452. 
79. Abe, H., Sakumoto, R., and Okuda, K. (2015). Expression of matrix 
metalloproteinases in bovine luteal cells induced by prostaglandin F2α, 
interferon γ and tumor necrosis factor α. Journal of Reproduction and 
Development 61, 277–286. 
80. Shah, K.B., Tripathy, S., Suganthi, H., and Rudraiah, M. (2014). 
Profiling of Luteal Transcriptome during Prostaglandin F2-Alpha 
Treatment in Buffalo Cows: Analysis of Signaling Pathways Associated 
with Luteolysis. PLOS ONE 9, e104127. 
81. Chen, D. (2001). Induction of c-fos and c-jun Messenger Ribonucleic 
Acid Expression by Prostaglandin F2 Is Mediated by a Protein Kinase 
C-Dependent Extracellular Signal-Regulated Kinase Mitogen-Activated 
70 
 
 
 
Protein Kinase Pathway in Bovine Luteal Cells. Endocrinology 142, 
887–895. 
82. Stocco, C.O., Lau, L.F., and Gibori, G. (2002). A Calcium/Calmodulin-
dependent Activation of ERK1/2 Mediates JunD Phosphorylation and 
Induction of nur77 and 20α-hsd Genes by Prostaglandin F 2α in 
Ovarian Cells. Journal of Biological Chemistry 277, 3293–3302. 
83. Li, M., Xue, K., Ling, J., Diao, F., Cui, Y.-G., and Liu, J.-Y. (2010). The 
orphan nuclear receptor NR4A1 regulates transcription of key 
steroidogenic enzymes in ovarian theca cells. Molecular and Cellular 
Endocrinology 319, 39–46. 
84. Sharma, S.C., and Richards, J.S. (2000). Regulation of AP1 (Jun/Fos) 
Factor Expression and Activation in Ovarian Granulosa Cells Relation 
of JunD and Fra2 To Terminal Differentiation. Journal of Biological 
Chemistry 275, 33718–33728. 
85. Diaz, F.J., Luo, W., and Wiltbank, M.C. (2013). Prostaglandin F2α 
regulation of the mRNA for AP-1 transcriptional factors in porcine 
corpora lutea: Lack of induction of JUN and JUND in CL without 
luteolytic capacity. Domestic Animal Endocrinology 44, 98–108. 
86. Qi, L., Guo, N., Wei, Q., Jin, P., Wang, W., and Mao, D. (2018). The 
involvement of NR4A1 and NR4A2 in the regulation of the luteal 
function in rats. Acta Histochem. 120, 713–719. 
87. Weidong Le, Jie Dong, and Sheng Chen (2010). NR4A Subfamily 
(Academic Press). 
71 
 
 
 
88. Stocco, C.O., Zhong, L., Sugimoto, Y., Ichikawa, A., Lau, L.F., and 
Gibori, G. (2000). Prostaglandin F 2 α-induced Expression of 20α-
Hydroxysteroid Dehydrogenase Involves the Transcription Factor 
NUR77. Journal of Biological Chemistry 275, 37202–37211. 
89. Hughes, C.K., and Pate, J.L. (2019). Luteolysis and the Corpus 
Luteum of Pregnancy In The Ovary. Elsevier 269–292. 
90. Cao, X., Liu, W., Lin, F., Li, H., Kolluri, S.K., Lin, B., Han, Y., Dawson, 
M.I., and Zhang, X. (2004). Retinoid X Receptor Regulates 
Nur77/Thyroid Hormone Receptor 3-Dependent Apoptosis by 
Modulating Its Nuclear Export and Mitochondrial Targeting. Molecular 
Cell Biology 24, 9705–9725. 
91. Talbott, H., Hou, X., Qiu, F., Zhang, P., Guda, C., Yu, F., Cushman, 
R.A., Wood, J.R., Wang, C., Cupp, A.S., et al. (2017). Early 
transcriptome responses of the bovine midcycle corpus luteum to 
prostaglandin F2α includes cytokine signaling. Molecular and Cellular 
Endocrinology 452, 93–109. 
92. Yokoyama, K., Hiyama, A., Arai, F., Nukaga, T., Sakai, D., and 
Mochida, J. (2013). C-Fos Regulation by the MAPK and PKC 
Pathways in Intervertebral Disc Cells. PLOS ONE 8. 
93. Mamluk, R., Greber, Y., and Meidan, R. (1999). Hormonal Regulation 
of Messenger Ribonucleic Acid Expression for Steroidogenic Factor-1, 
Steroidogenic Acute Regulatory Protein, and Cytochrome P450 Side-
72 
 
 
 
Chain Cleavage in Bovine Luteal Cells. Biology of Reproduction 60, 
628–634. 
94. Sugino, N. (2014). Molecular mechanisms of luteinization. Obstetrics 
and Gynecological Science 57, 93–101. 
95. Grummer, R.R., and Carroll, D.J. (1988). A review of lipoprotein 
cholesterol metabolism: importance to ovarian function. Journal of 
Animal Science 66, 3160–3173. 
96. Strauss, J.F., Kishida, T., Christenson, L.K., Fujimoto, T., and Hiroi, H. 
(2003). START domain proteins and the intracellular trafficking of 
cholesterol in steroidogenic cells. Molecular and Cellular 
Endocrinology 202, 59–65. 
97. Selvaraj, V., Stocco, D.M., and Clark, B.J. (2018). Current knowledge 
on the acute regulation of steroidogenesis. Biology of Reproduction 99, 
13–26. 
98. Duarte, A., Poderoso, C., Cooke, M., Soria, G., Cornejo Maciel, F., 
Gottifredi, V., and Podestá, E.J. (2012). Mitochondrial Fusion Is 
Essential for Steroid Biosynthesis. PLOS ONE 7, e45829. 
99. Flis, V.V., and Daum, G. (2013). Lipid Transport between the 
Endoplasmic Reticulum and Mitochondria. Cold Spring Harb Perspect 
Biol 5. 
100. Sewer, M.B., and Li, D. (2008). Regulation of Steroid Hormone 
Biosynthesis by the Cytoskeleton. Lipids 43, 1109–1115. 
73 
 
 
 
101. Ford, S.P., and Chenault, J.R. (1981). Blood flow to the corpus luteum-
bearing ovary and ipsilateral uterine horn of cows during the oestrous 
cycle and early pregnancy. Journal of Reproduction and Fertility 62, 
555–562. 
102. Zerani, M., Dall’Aglio, C., Maranesi, M., Gobbetti, A., Brecchia, G., 
Mercati, F., and Boiti, C. (2007). Intraluteal regulation of prostaglandin 
F2 alpha-induced prostaglandin biosynthesis in pseudopregnant 
rabbits. Reproduction 133, 1005–1016. 
103. Tsujimoto, Y. (1998). Role of Bcl-2 family proteins in apoptosis: 
apoptosomes or mitochondria? Genes to Cells 3, 697–707. 
104. Sugino, N., Suzuki, T., Kashida, S., Karube, A., Takiguchi, S., and 
Kato, H. (2000). Expression of Bcl-2 and Bax in the Human Corpus 
Luteum during the Menstrual Cycle and in Early Pregnancy: Regulation 
by Human Chorionic Gonadotropin. Journal of Clinical Endocrinology 
and Metabolism 85, 4379–4386. 
105. Carambula, S.F., Matikainen, T., Lynch, M.P., Flavell, R.A., Gonçalves, 
P.B.D., Tilly, J.L., and Rueda, B.R. (2002). Caspase-3 is a pivotal 
mediator of apoptosis during regression of the ovarian corpus luteum. 
Endocrinology 143, 1495–1501. 
106. Rueda, B.R., Hendry, I.R., Tilly, J.L., and Hamernik, D.L. (1999). 
Accumulation of Caspase-3 Messenger Ribonucleic Acid and Induction 
of Caspase Activity in the Ovine Corpus Luteum Following 
74 
 
 
 
Prostaglandin F2α Treatment In Vivo. Biology of Reproduction 60, 
1087–1092. 
107. Liszewska, E., Rekawiecki, R., and Kotwica, J. (2005). Effect of 
progesterone on the expression of bax and bcl-2 and on caspase 
activity in bovine luteal cells. Prostaglandins & Other Lipid Mediators 
78, 67–81. 
108. Liu, B., Chen, Y., and St. Clair, D.K. (2008). ROS and p53: versatile 
partnership. Free Radical Biology and Medicine 44, 1529–1535. 
109. Walusimbi, S.S., and Pate, J.L. (2014). Luteal Cells from Functional 
and Regressing Bovine Corpora Lutea Differentially Alter the Function 
of Gamma Delta T Cells. Biology of Reproduction 90. 
110. Taniguchi, H., Yokomizo, Y., and Okuda, K. (2002). Fas-Fas Ligand 
System Mediates Luteal Cell Death in Bovine Corpus Luteum. Biology 
of Reproduction 66, 754–759. 
111. Pru, J.K., Hendry, I.R., Davis, J.S., and Rueda, B.R. (2002). Soluble 
Fas ligand activates the sphingomyelin pathway and induces apoptosis 
in luteal steroidogenic cells independently of stress-activated 
p38(MAPK). Endocrinology 143, 4350–4357. 
112. Galvão, A.M., Ferreira-Dias, G., and Skarzynski, D.J. (2013). 
Cytokines and Angiogenesis in the Corpus Luteum. Mediators of 
Inflammation 2013. 
113. Childs, S., Hennessy, A.A., Sreenan, J.M., Wathes, D.C., Cheng, Z., 
Stanton, C., Diskin, M.G., and Kenny, D.A. (2008). Effect of level of 
75 
 
 
 
dietary n-3 polyunsaturated fatty acid supplementation on systemic 
and tissue fatty acid concentrations and on selected reproductive 
variables in cattle. Theriogenology 70, 595–611. 
114. Burke, J.M., Staples, C.R., Risco, C.A., De La Sota, R.L., and 
Thatcher, W.W. (1997). Effect of Ruminant Grade Menhaden Fish 
Meal on Reproductive and Productive Performance of Lactating Dairy 
Cows. Journal of Dairy Science 80, 3386–3398. 
115. Weaver, L.D. (1987). Effects of Nutrition on Reproduction in Dairy 
Cows. Veterinary Clinics of North America: Food Animal Practice 3, 
513–532. 
116. Harnack, K., Andersen, G., and Somoza, V. (2009). Quantitation of 
alpha-linolenic acid elongation to eicosapentaenoic and 
docosahexaenoic acid as affected by the ratio of n6/n3 fatty acids. 
Nutrition and Metabolism (Lond) 6, 8. 
117. Burns, P.D., Engle, T.E., Harris, M.A., Enns, R.M., and Whittier, J.C. 
(2003). Effect of fish meal supplementation on plasma and endometrial 
fatty acid composition in nonlactating beef cows. Journal of Animal 
Science 81, 2840–2846. 
118. Moussavi, A.R.H., Gilbert, R.O., Overton, T.R., Bauman, D.E., and 
Butler, W.R. (2007). Effects of feeding fish meal and n-3 fatty acids on 
ovarian and uterine responses in early lactating dairy cows. Journal of 
Dairy Science 90, 145–154. 
76 
 
 
 
119. White, N.R., Burns, P.D., Cheatham, R.D., Romero, R.M., Nozykowski, 
J.P., Bruemmer, J.E., and Engle, T.E. (2012). Fish meal 
supplementation increases bovine plasma and luteal tissue omega-3 
fatty acid composition1. Journal of Animal Science 90, 771–778. 
120. Zhangrui Cheng, Robert S Robinson, Anil Pushpakumara, D Claire 
Wathes, and R J Mansbridge (12/01). Effect of dietary polyunsaturated 
fatty acids on uterine prostaglandin synthesis in the cow. Journal of 
Endocrinology 171, 463–473. 
121. Abayasekara, D.R.E., and Wathes, D.C. (1999). Effects of altering 
dietary fatty acid composition on prostaglandin synthesis and fertility. 
Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) 61, 
275–287. 
122. Caldari-Torres, C., Rodriguez-Sallaberry, C., Greene, E.S., and 
Badinga, L. (2006). Differential Effects of n-3 and n-6 Fatty Acids on 
Prostaglandin F2α Production by Bovine Endometrial Cells. Journal of 
Dairy Science 89, 7. 
123. Plewes, M.R., Burns, P.D., Graham, P.E., Hyslop, R.M., and Barisas, 
B.G. (2017). Effect of fish oil on lateral mobility of prostaglandin F2α 
(FP) receptors and of lipid microdomains in bovine luteal cell plasma 
membrane in vitro. Domestic Animal Endocrinology 58, 39–52. 
124. Plewes, M.R., Burns, P.D., Graham, P.E., Bruemmer, J.E., Engle, T.E., 
and Barisas, B.G. (2017). Effect of fish meal supplementation on 
spatial distribution of lipid microdomains and on the lateral mobility of 
77 
 
 
 
membrane-bound prostaglandin F2α receptors in bovine corpora lutea. 
Domestic Animal Endocrinology 60, 9–18. 
125. Plewes, M.R., Burns, P.D., Graham, P.E., Bruemmer, J.E., and Engle, 
T.E. (2018). Influence of omega-3 polyunsaturated fatty acids from fish 
oil or meal on the structure of lipid microdomains in bovine luteal cells. 
Animal Reproduction Science 193, 40–57. 
126. Diskin, M.G., and Morris, D.G. (2008). Embryonic and Early Foetal 
Losses in Cattle and Other Ruminants. Reproduction in Domestic 
Animals 43, 260–267. 
127. Plewes, M.R., Cedillo, J.C., Burns, P.D., Graham, P.E., Bruemmer,  
J.E., and Engle, T.E. (2018). Effect of fish meal supplementation on  
luteal sensitivity to intrauterine infusions of prostaglandin F2α in the  
bovine. Biology of Reproduction 98, 543–557. 
128. Livak, K.J., and Schmittgen, T.D. (2001). Analysis of Relative Gene 
Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT 
Method. Methods 25, 402–408. 
129. Burns, P.D., Spitzer, J.C., and Henricks, D.M. (1997). Effect of dietary 
energy restriction on follicular development and luteal function in 
nonlactating beef cows. Journal of Animal Science 75, 1078–1086. 
130. Butler, W.R. (2000). Nutritional interactions with reproductive 
performance in dairy cattle. Animal Reproduction Science 60–61, 449–
457. 
78 
 
 
 
131. Gomez, N.A., Conley, A.J., and Robinson, P.H. (2018). Effects of long-
term, near-term, and real-time energy balance, and blood 
progesterone concentrations, on the pregnancy rate of contemporary 
dairy cows. Animal Reproduction Science 189, 136–145. 
132. Grummer, R.R., and Carroll, D.J. (1991). Effects of dietary fat on 
metabolic disorders and reproductive performance of dairy cattle. 
Journal of Animal Science 69, 3838–3852. 
133. Reiser, R., and Ramakrishna Reddy, H.G. (1956). The hydrogenation 
of dietary unsaturated fatty acids by the ruminant. Journal of the 
American Oil Chemists Society 33, 155–156. 
134. Robinson, R.S., Pushpakumara, P.G.A., Cheng, Z., Peters, A.R., 
Abayasekara, D.R.E., and Wathes, D.C. (2002). Effects of dietary 
polyunsaturated fatty acids on ovarian and uterine function in lactating 
dairy cows. Reproduction 124, 119–131. 
135. Wamsley, N.E., Burns, P.D., Engle, T.E., and Enns, R.M. (2005). Fish 
meal supplementation alters uterine prostaglandin F2α synthesis in 
beef heifers with low luteal-phase progesterone. Journal of Animal 
Science 83, 1832–1838. 
136. Mattos, R., Staples, C.R., and Thatcher, W.W. (2000). Effects of 
dietary fatty acids on reproduction in ruminants. Reviews in 
Reproduction 5, 38–45. 
79 
 
 
 
137. Kot, K., Anderson, L.E., Tsai, S.-J., Wiltbank, M.C., and Ginther, O.J. 
(1999). Transvaginal, ultrasound-guided biopsy of the corpus luteum in 
cattle. Theriogenology 52, 987–993. 
138. Atli, M.O., Bender, R.W., Mehta, V., Bastos, M.R., Luo, W., Vezina, 
C.M., and Wiltbank, M.C. (2012). Patterns of Gene Expression in the 
Bovine Corpus Luteum Following Repeated Intrauterine Infusions of 
Low Doses of Prostaglandin F2alpha. Biology of Reproduction 86. 
139. Wiltbank, M.C., and Ottobre, J.S. (2003). Regulation of intraluteal 
production of prostaglandins. Reproduction and Biology Endocrinology 
1, 91. 
140. Adams, J.M., and Cory, S. (1998). The Bcl-2 Protein Family: Arbiters of 
Cell Survival. Science 281, 1322–1326. 
141. Skarzynski, D.J., Jaroszewski, J.J., and Okuda, K. (2005). Role of 
tumor necrosis factor-α and nitric oxide in luteolysis in cattle. Domestic 
Animal Endocrinology 29, 340–346. 
142. Nakamura, T., and Sakamoto, K. (2001). Reactive Oxygen Species 
Up-Regulates Cyclooxygenase-2, p53, and Bax mRNA Expression in 
Bovine Luteal Cells. Biochemical and Biophysical Research 
Communications 284, 203–210. 
143. Walsh, J.G., Logue, S.E., Lüthi, A.U., and Martin, S.J. (2011). 
Caspase-1 Promiscuity Is Counterbalanced by Rapid Inactivation of 
Processed Enzyme. Journal of Biological Chemistry 286, 32513–
32524. 
80 
 
 
 
144. Yadav, V.K., Lakshmi, G., and Medhamurthy, R. (2005). Prostaglandin 
F 2α -mediated Activation of Apoptotic Signaling Cascades in the 
Corpus Luteum during Apoptosis: INVOLVEMENT OF CASPASE-
ACTIVATED DNase. Journal of Biological Chemistry 280, 10357–
10367. 
145. Yang, Y., Sun, M., Shan, Y., Zheng, X., Ma, H., Ma, W., Wang, Z., Pei, 
X., and Wang, Y. (2015). Endoplasmic Reticulum Stress-Mediated 
Apoptotic Pathway Is Involved in Corpus Luteum Regression in Rats. 
Reproduction Science 22, 572–584. 
146. Chen, D., and Davis, J.S. (2003). Epidermal growth factor induces c-
fos and c-jun mRNA via Raf-1/MEK1/ERK-dependent and -
independent pathways in bovine luteal cells. Molecular Cell 
Endocrinology 200, 141–154. 
147. Chen, D., Fong, H.W., and Davis, J.S. (2001). Induction of c-fos and c-
jun Messenger Ribonucleic Acid Expression by Prostaglandin F2α Is 
Mediated by a Protein Kinase C-Dependent Extracellular Signal-
Regulated Kinase Mitogen-Activated Protein Kinase Pathway in Bovine 
Luteal Cells. Endocrinology 142, 887–895. 
148. Plewes, M.R., and Burns, P.D. (2018). Effect of fish oil on agonist-
induced receptor internalization of the PG F 2α receptor and cell 
signaling in bovine luteal cells in vitro. Domestic Animal Endocrinology 
63, 38–47. 
81 
 
 
 
149. Plewes, M.R., Burns, P.D., Hyslop, R.M., and Barisas, B.G. (2017). 
Influence of omega-3 fatty acids on bovine luteal cell plasma 
membrane dynamics. Biochimica et Biophysica Acta 1859, 2413–
2419. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
82 
 
 
 
 
 
 
 
 
APPENDIX A 
 
INSTITUTIONAL ANIMAL CARE AND USE  
COMMITTEE APPROVAL 
 
 
 
 
 
 
 
 
 
 
 
 
83 
 
 
 
 
84 
 
 
 
 
 
 
 
 
 
 
 
85 
 
 
 
 
 
 
 
 
APPENDIX B 
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